WO2023124540A1 - Implant capable of accelerating endothelialization and transcatheter cardiac repair system - Google Patents

Implant capable of accelerating endothelialization and transcatheter cardiac repair system Download PDF

Info

Publication number
WO2023124540A1
WO2023124540A1 PCT/CN2022/130084 CN2022130084W WO2023124540A1 WO 2023124540 A1 WO2023124540 A1 WO 2023124540A1 CN 2022130084 W CN2022130084 W CN 2022130084W WO 2023124540 A1 WO2023124540 A1 WO 2023124540A1
Authority
WO
WIPO (PCT)
Prior art keywords
anchoring
spacer
wire
tightening
anchor
Prior art date
Application number
PCT/CN2022/130084
Other languages
French (fr)
Chinese (zh)
Inventor
匡经旭
郭荣辉
张庭超
Original Assignee
杭州德晋医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 杭州德晋医疗科技有限公司 filed Critical 杭州德晋医疗科技有限公司
Publication of WO2023124540A1 publication Critical patent/WO2023124540A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2466Delivery devices therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436Deployment by retracting a sheath
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/246Devices for obstructing a leak through a native valve in a closed condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol

Definitions

  • the present application relates to the technical field of medical devices, in particular to an implant capable of accelerating endothelialization and a transcatheter heart repair system.
  • Mitral regurgitation is a common heart valve disease, including primary mitral regurgitation and secondary mitral regurgitation.
  • Primary mitral regurgitation is due to abnormal mitral valve leaflets, chordal rupture or papillary muscle insufficiency leading to poor anastomosis of the anterior and posterior leaflets of the mitral valve, resulting in blood regurgitation;
  • secondary mitral regurgitation is due to Annulus expansion, left atrium and left ventricle enlargement lead to poor anastomosis of the anterior and posterior leaflets of the mitral valve, resulting in blood regurgitation. Therefore, the mitral annulus can be constricted or the left ventricle can be narrowed to reduce secondary mitral regurgitation.
  • the prior art discloses a transcatheter left ventricular repair system, as shown in Figure 1, which alternately wears several anchors 1b and several spacers 1c on a thread 1a, wherein each anchor 1b can be implanted Left ventricular wall 1d.
  • the silk thread 1a is pulled toward the proximal end (as shown in the L0 direction in Figure 1), and several spacers 1c and several anchors 1b implanted in the left ventricle wall 1d are along the silk thread 1a. Close to each other to achieve the contraction of the left ventricle, and then treat mitral regurgitation.
  • the present application provides an implant that can accelerate endothelialization and a transcatheter heart repair system.
  • the present application firstly provides an implant capable of accelerating endothelialization, which includes multiple anchor components, multiple spacers and tightening wires.
  • An anchor assembly is used to anchor into cardiac tissue.
  • the spacer is elastic in its axial direction.
  • a plurality of anchor components and a plurality of spacers are alternately worn on the tightening wire, and the distal end of the tightening wire is connected with the first anchor component for anchoring into the heart tissue.
  • each spacer Since each spacer has elasticity in its axial direction, each spacer is squeezed and compressed in the axial direction by the two anchor components adjacent to it, so that the end surface of each spacer along its axial direction is in line with its corresponding Adjacent anchoring components fit together, eliminating the gap between the anchoring component and the spacer, accelerating the endothelialization of the implant after it is implanted into the heart tissue, and reducing the risk in the later stage of the operation.
  • the present application also provides a transcatheter heart repair system, which includes a delivery device, an anchoring device and the above-mentioned implant capable of accelerating endothelialization.
  • the delivery device includes a delivery sheath.
  • the anchoring device is movably installed in the lumen of the delivery sheath, the anchoring assembly is installed in the distal end of the delivery sheath, the anchoring assembly is detachably connected to the distal end of the anchoring device, and the delivery sheath is used to The anchor component is delivered to the heart tissue, and the anchor device is used to drive the anchor component to anchor into the heart tissue.
  • Fig. 1 is a schematic diagram of the structure of the left ventricle narrowed by the transcatheter left ventricle repair system provided by the prior art.
  • Fig. 2 is a schematic structural view of the implant provided in the embodiment of the present application.
  • Fig. 3 is a schematic structural view of the implant provided in the embodiment of the present application in a tightened state.
  • FIG. 4 is a schematic structural view of the spacer (with the film omitted) in FIG. 3 in a natural state.
  • Fig. 5 is an exploded schematic view of the spacer in Fig. 3 in a natural state.
  • Fig. 6 is a cross-sectional view of the spacer in Fig. 5 after being assembled along its axial direction.
  • FIG. 7 is a schematic structural view of the spacer (with the film omitted) in FIG. 3 in a fully compressed state.
  • FIG. 8 is an enlarged view of part VIII in FIG. 3 .
  • FIG. 9 is a schematic structural view of the spacer (with the film omitted) in FIG. 3 in an incompletely compressed state.
  • Fig. 10 is an enlarged view of part X in Fig. 3 .
  • FIG. 11 is a schematic structural view of another embodiment of the spacer (with the film omitted) in FIG. 3 in a natural state.
  • Fig. 12 is a schematic structural view of the spacer in Fig. 11 in a compressed state.
  • Fig. 13 is a structural schematic diagram of the anchor assembly in Fig. 3 .
  • Fig. 14 is a schematic structural diagram of the wire take-up in Fig. 3 .
  • Fig. 15 is a structural schematic diagram of the section along XV-XV after the wire take-up in Fig. 14 cooperates with the tightening wire.
  • Fig. 16 is a schematic structural view of the wire take-up (with the shell omitted) in Fig. 14 .
  • Fig. 17 is a partial cross-sectional view of the wire take-up and the adjustment tool in Fig. 14 assembled.
  • Fig. 18 is a partial structural schematic diagram of a transcatheter heart repair system provided by an embodiment of the present application.
  • Fig. 19 is a schematic structural view of the assembled anchoring device and anchoring assembly provided in the embodiment of the present application.
  • Fig. 20 is a schematic diagram showing the anchoring device of Fig. 19 separated from the anchoring assembly.
  • Fig. 21 is a cross-sectional view of Fig. 19 taken along the central axis of the drive tube.
  • Fig. 22 is a structural schematic diagram of the assembled tightening wire, anchor assembly, anchor device and delivery sheath in Fig. 18 .
  • FIG. 23 to 28 are schematic views of the application process of the transcatheter heart repair system provided by the embodiment of the present application in mitral annuloplasty; wherein, FIG. 24 is an enlarged view of part XXIV in FIG. 23 .
  • proximal end the end close to the operator
  • distal end the end far away from the operator
  • the central axis of "part A” refers to the geometric centerline of "part A”.
  • the connection between “part A” and “part B” may be a direct contact connection between “part A” and “part B”, or an indirect connection between “part A” and “part B” through “part C”.
  • end is not limited to the end, end point or end face, but also includes from the end, end point, or end face at the end, end point, or The portion of the element to which the end face belongs extends an axial distance and/or a radial distance.
  • the embodiment of the present application provides an implant 100 that can accelerate endothelialization, which can be applied to annuloplasty or ventricular volume reduction, and it can be implanted and left in the mitral valve Ring 1, tricuspid valve ring, left ventricle wall or right ventricle wall and other heart tissues, to directly shrink the valve ring or reduce the volume of the ventricle by narrowing the ventricle to achieve the purpose of shrinking the valve ring, so as to achieve mitral regurgitation or tricuspid regurgitation treatment.
  • volume reduction of the left ventricle can also treat ischemic heart failure.
  • the implant 100 is generally C-shaped or ring-shaped after being implanted in the annulus or the wall of the ventricle.
  • the heart tissue is the mitral valve ring 1 , and the mitral valve ring 1 is shown in a straight line to make the illustration more intuitive.
  • heart tissue is used as the mitral valve annulus 1 below, and the implant 100 is implanted and left on the mitral valve annulus 1 to shrink the mitral valve annulus 1 and realize the treatment of mitral regurgitation Take as an example for specific description.
  • the implant 100 includes a plurality of anchor assemblies 10 , a plurality of spacers 20 and tightening wires 30 .
  • the anchoring assembly 10 is used for anchoring into cardiac tissue (ie the mitral valve annulus 1).
  • the spacer 20 has elasticity in its axial direction.
  • a plurality of anchoring assemblies 10 and a plurality of spacers 20 are alternately worn on the tightening wire 30, and the distal end of the tightening wire 30 is connected to the first anchoring assembly 10 for anchoring into the heart tissue (as shown in FIG. 2 ).
  • the anchor assembly 10a) is connected.
  • the spacer 20 is threaded on the tightening wire 30 along its axial direction.
  • the first anchor assembly 10 refers to the anchor assembly 10 that is first delivered to the heart tissue in chronological order among the plurality of anchor assemblies 10, and the “last anchor assembly 10” refers to the anchor assembly 10 of the plurality of anchor assemblies 10.
  • the anchoring components 10 that are finally delivered to the heart tissue in chronological order "the second anchoring component 10", “the third anchoring component 10” and so on can be understood similarly; 20", “the second spacer 20”, “the last spacer 20” and other descriptions can be understood similarly.
  • each spacer 20 Since each spacer 20 has elasticity in its axial direction, each spacer 20 is squeezed by the two anchor assemblies 10 adjacent to it and compressed in the axial direction, so that the end surface of each spacer 20 along the axial direction Adjacent anchoring components 10 fit together, eliminating the gap between the anchoring components 10 and the spacer 20 , accelerating the endothelialization of the implant 100 after it is implanted in the mitral annulus 1 , and reducing the risk in the later stage of the operation.
  • such a design greatly reduces the requirement for the distance between adjacent anchor components 10 when they are implanted, and the distance between adjacent anchor components 10 during implantation does not need to be uniform, which reduces the difficulty of operation and is conducive to improving surgical efficiency.
  • the spacer 20 can prevent the excessive tightening of the tightening wire 30 from causing the distance between two adjacent anchoring assemblies 10 to be too short and damage the mitral valve annulus 1.
  • the spacer 20 can play a buffer role and disperse the anchoring The pulling force received by the component 10 ensures that the anchor component 10 is anchored stably.
  • the number of anchor components 10 is only three, which are respectively anchor component 10a, anchor component 10b and anchor component 10c; the number of spacers 20 is only two, They are the spacer 20a and the spacer 20b respectively.
  • the number of the anchor assembly 10 is more than three, and the number of the spacer 20 is more than two.
  • the number of anchoring components 10 is at least three, and the number of spacers 20 is at least two. The application does not specifically limit the number of anchoring components 10 and spacers 20 .
  • the anchoring assembly 10a is connected with the distal end of the tightening wire 30, and the distal end of the tightening wire 30 is delivered to the mitral annulus 1 along with the anchoring assembly 10a; when the anchoring assembly 10a is anchored into the mitral After the valve annulus 1, the spacer 20a is inserted from the proximal end of the tightening wire 30 and delivered to the mitral annulus 1 along the tightening wire 30; then the anchor assembly 10b is inserted from the proximal end of the tightening wire 30 And delivered along the tightening wire 30 and anchored into the mitral annulus 1; similarly, the spacer 20b and the anchoring assembly 10c are delivered to the mitral annulus 1 in sequence, and the anchoring assembly 10c is then anchored into the mitral annulus Ring 1.
  • the anchor assembly 10a and the anchor assembly 10b approach each other and squeeze the spacer 20a, so that the spacer 20a is compressed along its axial direction, and the spacer 20a is compressed along its axial direction.
  • the opposite end faces of the anchoring assembly 10a and the anchoring assembly 10b are attached respectively; the anchoring assembly 10b and the anchoring assembly 10c approach each other and press the spacer 20b, so that the second spacer 21 is compressed along its axial direction, and the spacer
  • the opposite ends of the member 20b along the axial direction are attached to the anchoring component 10b and the anchoring component 10c respectively.
  • spacer 20 may be a compression spring.
  • the compression spring When the compression spring is compressed along its axial direction, the two opposite end surfaces of the compression spring in the axial direction can be attached to the two anchor assemblies 10 respectively, so that the gap between the compression spring and the anchor assembly 10 can be eliminated, To reduce the time for implant 100 to endothelialize.
  • the spacer 20 also has elasticity in its radial direction. When the spacer 20 is compressed along its axial direction, the spacer 20 expands along its radial direction to make the spacer 20
  • the outer peripheral surface of the valve body is attached to the heart tissue (that is, the mitral valve annulus 1). It can be understood that due to irresistible factors such as manual operation, the anchoring depths of all anchoring components 10 into the mitral annulus 1 cannot be guaranteed to be all the same.
  • the spacer 20 includes a main body 21 having an axial inner cavity 211 , and the main body 21 is made of a shape memory material.
  • the main body portion 21 is compressed in its axial direction so that the main body portion 21 expands in its radial direction.
  • the axial direction of the spacer 20 is the same as the axial direction of the main body 21
  • the axial cavity 211 runs through the opposite end surfaces of the main body 21 in the axial direction
  • the tightening wire 30 can pass through the axial inner portion of the main body 21 .
  • the lumen 211 thus threads the spacer 20 over the cinch wire 30 .
  • the main body 21 when the spacer 20 is compressed in the axial direction, that is, the main body 21 is compressed in the axial direction and expands in the radial direction, so that the end surface of the spacer 20 in the axial direction is in close contact with the anchor assembly 10 adjacent to it.
  • the main body 21 since the main body 21 is made of shape memory material, the main body 21 can adapt to the shape of different structural tissues and deform, so that there is a larger contact area between the outer peripheral surface of the spacer 20 and the mitral annulus 1 , further shortening the time of endothelialization.
  • the shape memory material may be Ti—Ni-based shape memory alloy, copper-based shape-memory alloy, iron-based shape-memory alloy, shape-memory polymer, etc., such as nickel-titanium alloy, which is not limited in this application.
  • the radial dimension of the main body portion 21 gradually decreases from the middle to both ends along its axial direction, in other words, the axial length of the main body portion 21
  • the radial dimension A1 at the middle position is the largest.
  • the main body portion 21 when the main body portion 21 is compressed along its axial direction, the main body portion 21 will only expand outwardly along its radial direction, and will not be squeezed inward, so as to ensure that the outer peripheral surface of the spacer 20 is in contact with the mitral valve annulus 1 (such as As shown in Figure 3) can be in stable contact.
  • the natural state refers to the state where the main body 21 is not subjected to any external force, that is, the main body 21 is not deformed.
  • the main body portion 21 when the main body portion 21 is in a natural state, the main body portion 21 is an elliptical cylinder. It can be understood that the main body 21 can also be an ellipsoid. In other embodiments, the main body 21 can also be an elongated water droplet, that is to say, when the main body 21 is in a natural state, the two ends of the radial dimension of the main body 21 are small, the middle is large, and the maximum radial dimension Off-axis mid-position.
  • the spacer 20 further includes two fixing pieces 22 , the fixing pieces 22 are provided with a wire passing hole 221 along its axial direction, and the two fixing pieces 22 are respectively arranged on the main body portion 21 The two ends in the axial direction, the wire passing hole 221 communicates with the axial inner chamber 211 . It can be understood that when the spacer 20 is worn on the tightening wire 30, the tightening wire 30 passes through the wire passing hole 221 of one fixing member 22, the axial inner cavity 211 of the main body 21 and the opening of the other fixing member 22 in sequence. Wire hole 221 .
  • the two anchor assemblies 10 adjacent to the spacer 20 approach each other and press the two fixing members 22, and the two fixing members 22 approach each other along the axial direction of the main body portion 21, and the main body portion 21 is axially compressed.
  • the design of the fixing member 22 ensures that the main body 21 can be evenly stressed, which is beneficial to the deformation of the main body 21 .
  • the spacer 20 further includes a rigid member 23, the rigid member 23 is provided with a threading hole 231 along its axial direction, the rigid member 23 is accommodated in the axial cavity 211 and is located on both sides. Between the two fixing pieces 22, the threading hole 231 is connected to the threading hole 221.
  • the tightening wire 30 passes through the wire passing hole 221 of one fixing member 22 along the axial direction of the main body portion 21 and penetrates into the axial inner cavity 211, and then passes through the wire passing hole 231 from the wire passing hole of the other fixing member 22.
  • the spacer 20 can be worn on the tightening line 30.
  • the main body 21 When the main body 21 is in a natural state, there is an axial distance between the rigid member 23 and at least one fixing member 22 to ensure that when the tightening wire 30 is tightened, the main body 21 can be compressed in the axial direction.
  • the two fixing members 22 approach each other along the axial direction of the main body 21 and press against the rigid member 23, the main body 21 is axially compressed, and the rigid member 23 can limit the main body. 21, so as to prevent the main body 21 from being over-compressed and crushed, causing the main body 21 to lose its elastic force in the radial direction.
  • the rigid member 23 when the rigid member 23 is accommodated in the axial cavity 211, it can move freely.
  • the rigid member 23 is a steel pipe with an inner diameter smaller than the outer diameter of the fixing member 22 and an outer diameter larger than the inner diameter of the fixing member 22, so that when the spacer 20 is subjected to excessive axial force, the rigid member can be guaranteed 23 is always located in the axial cavity 211 of the main body 21 , and the fixing part 22 can press the rigid part 23 stably.
  • the main body 21 is a mesh structure
  • the fixing member 22 includes an outer casing 222 and an inner casing 223 sleeved in the axial direction, and the free end of the mesh structure is extruded It is accommodated between the outer sleeve 222 and the inner sleeve 223 .
  • the main body 21 of the mesh structure has high elasticity and good flexibility, and is easy to deform, so that when the main body 21 expands in the radial direction, it is beneficial for the outer peripheral surface of the spacer 20 to better align with the mitral annulus 1.
  • the contact area between the outer peripheral surface of the spacer 20 and the mitral annulus 1 is further increased, and the endothelialization time is further shortened.
  • the main body 21 is woven into a mesh structure by a plurality of nickel-titanium wires, which is shaped after heat treatment and has an elliptical cylinder appearance.
  • the nickel-titanium wires at both axial ends i.e. the free ends
  • the nickel-titanium wires at both ends are squeezed and accommodated in a fixing member 22 respectively.
  • the nickel-titanium wire at one end is folded and gathered into the lumen 224 of the outer sleeve 222 of a fixing member 22, and then the inner sleeve 223 is squeezed along the main body
  • the axial direction of part 21 is squeezed into the lumen 224, and the nickel-titanium wire at the end is fixed by the friction force between it and the outer sleeve 222 and the inner sleeve 223, so that the nickel-titanium wire at the end is squeezed and accommodated in the outer sleeve 222 and the outer wall of the inner sleeve 223.
  • the lumen of the inner sleeve 223 is the wire passing hole 221 of the fixing member 22, that is to say, when the spacer 20 is worn on the tightening wire 30, the tightening wire 30 passes through it sequentially.
  • the material of the outer casing 222 and the inner casing 223 is SUS316Lvm, that is, both are stainless steel pipes. In other embodiments, the material of the outer sleeve 222 and the inner sleeve 223 may also be other materials, which are not specifically limited in this application.
  • the fixing member 22 is located in the axial inner cavity 211 of the main body 21 as a whole, and the spacer 20
  • the two ends along the axial direction are meshed nickel-titanium wires, and the nickel-titanium wires have good elasticity.
  • the spacer 20 is axially compressed, the two ends of the spacer 20 along the axial direction better fit the adjacent anchor assembly 10 .
  • the main body 21 includes a plurality of support bars 212 distributed at intervals
  • the fixing member 22 is a fixing tube
  • the plurality of support bars 212 are arranged around the circumference of the fixing tube 22 . It can be understood that, in a natural state, the middle portion of each support bar 212 protrudes outward along the radial direction of the spacer 20 , so that the radially middle dimension A1 of the main body portion 21 is larger than the end portion thereof.
  • the support bar 212 will expand outward along the radial direction of the main body 21, which is beneficial to the contact between the outer peripheral surface of the spacer 20 and the heart tissue (ie, the mitral valve annulus 1) Touch and fit.
  • the support strip 212 due to the relatively small width and thickness of the support strip 212 itself, when the spacer 20 contacts the mitral valve annulus 1 and the support strip 212 is subjected to radial pressure, the support strip 212 can also be deformed to be in contact with the mitral valve.
  • the fit of the ring 1 increases the contact area between the spacer 20 and the mitral valve ring 1, which is beneficial to further shorten the time for endothelialization.
  • the main body portion 21 in the shape of an elliptical cylinder.
  • the main body 21 and the two fixing members 22 of the spacer 20 can be made of a tube made of a shape memory material, such as a nickel-titanium tube. Specifically, a whole piece of nickel-titanium tube can be cut and processed, and then placed in a specific mold for heat setting.
  • a shape memory material such as a nickel-titanium tube.
  • the spacer 20 further includes a covering film 24 , the covering film 24 is elastic, and the covering film 24 covers the outside of the main body portion 21 and is fixedly connected with the main body portion 21 .
  • the covering film 24 plays a role of protection, preventing the main part 21 from rubbing against the mitral valve annulus 1 and causing damage to the mitral valve annulus 1 .
  • the covering film 24 can be fixedly connected with the main body portion 21 having a mesh structure by means of sutures.
  • the covering film 24 is made of a polymer material with good biocompatibility, such as PET (Polyethylene Glycol Terephthalate, polyethylene terephthalate), PTFE (Poly tetra Fluoroethylene, polytetrafluoroethylene), etc. , which is not limited in this application.
  • PET Polyethylene Glycol Terephthalate, polyethylene terephthalate
  • PTFE Poly tetra Fluoroethylene, polytetrafluoroethylene
  • the main body portion 21 surrounded by a plurality of support bars 212 can also be covered with a coating film 24 .
  • the spacer 20a when the tightening wire 30 is tightened, the spacer 20a is squeezed by the anchoring component 10a and the anchoring component 10b, and its opposite ends in the axial direction are in contact with the anchoring component 10a and the anchoring component respectively.
  • 10b at the same time, its radial dimension becomes larger and fits with the mitral valve annulus 1;
  • the spacer 20b is squeezed by the anchoring assembly 10b and the anchoring assembly 10c, and its opposite ends in the axial direction are respectively It fits with the anchoring component 10b and the anchoring component 10c, and at the same time, its radial dimension becomes larger and fits with the mitral valve annulus 1 .
  • the anchoring assembly 10a, the spacer 20a, the anchoring assembly 10b, the spacer 20b, the anchoring assembly 10c and the mitral valve ring 1 are connected together in terms of positional relationship.
  • the traction force of the tightening wire 30 should be smaller than the anchoring force of the anchoring assembly 10 on the mitral valve annulus 1, thus tightening
  • the anchor assembly 10 will not break away from the mitral valve annulus 1, ensuring that the implant 100 can stably shrink the mitral valve annulus 1.
  • the contraction amount of the mitral annulus 1 also depends on the tissue stiffness of the mitral annulus 1 itself. It can be understood that the tissue hardness at different positions of the mitral valve annulus 1 is different, among which, the hardness of the anterior trigone and the posterior trigone is the hardest.
  • the anchoring assembly 10a and the anchoring assembly 10b squeeze the spacer 20a, and the spacer 20a is completely compressed due to the large contraction of the annulus tissue between the anchoring assembly 10a and the anchoring assembly 10b. Compression (such as the spacer 20 shown in FIG. 7), its main body 21 can no longer be compressed along its axial direction, and the spacer 20a is rigid in its axial direction. As shown in Figures 9 and 10, the anchoring assembly 10b and the anchoring assembly 10c press the spacer 20b, and the spacer 20b is not compressed due to the small contraction of the annulus tissue between the anchoring assembly 10b and the anchoring assembly 10c. When fully compressed (as shown in the spacer 20 in FIG.
  • its main body 21 can continue to compress along its axial direction, and the spacer 20b still has elasticity in its axial direction. It can be understood that the radial dimension of the spacer 20 a at its axial middle position is larger than the radial dimension of the spacer 20 b at its axial middle position.
  • the spacer 20a Since the spacer 20a is rigid and cannot be further compressed, the pulling force received by the anchoring component 10a and the anchoring component 10b will be distributed to the remaining anchoring components 10, such as the anchoring component 10c, so that the anchoring component 10b and the anchoring component 10c The space between the components 10c will continue to be narrowed, and the spacer 20b will be further compressed until the ideal effect on the constriction of the mitral annulus 1 is achieved, that is, mitral valve regurgitation is weakened or disappeared.
  • the number of anchor assemblies 10 exceeds three and the number of spacers 20 exceeds two, if the spacers 20b are fully compressed and become rigid, the constriction of the mitral annulus 1 has not yet achieved the desired effect, and may Continue to tighten the tightening wire 30, the pulling force continues to increase, and the pulling force received by the anchor assembly 10b and the anchor assembly 10c will be partially transmitted to the next anchor assembly 10, so as to further strengthen the next spacer 20. Compression, and so on until the mitral valve regurgitation weakens or disappears.
  • each anchor assembly 10 receives approximately the same pulling force from the tightening wire 30, but since the anchor assembly 10 is implanted in Different locations of the mitral annulus 1, and the tissue at each location of the mitral annulus 1 itself varies in softness and hardness. In places where the hardness of the annulus tissue is softer, the amount of contraction is greater, and two adjacent anchors The axial compression amount of the spacer 20 between the components 10 is relatively large; where the annulus tissue hardness is relatively hard, the contraction amount is small, and the spacer 20 between two adjacent anchoring components 10 is squeezed. The pressure is less, and its axial compression is less.
  • the spacer 20 at the softer part of the annulus is easier to be completely compressed and becomes rigid, and the two adjacent anchor components 10 can disperse the excess pulling force to other anchor components 10, so as to facilitate further compression deformation of other spacers 20, and achieve the ideal effect of shrinking rings. Since the axial length of the spacer 20 itself is long and it can expand radially, in the implant 100 implanted in the mitral valve annulus 1, the spacer 20 and the two adjacent anchor assemblies 10 And the mitral annulus 1 has a larger contact area, which eliminates the gap as much as possible, which is beneficial to the endothelialization of the implant 100 better and faster.
  • the anchoring assembly 10 includes an anchor 11 and a threading structure 12 arranged on the anchor 11, and the distal end of the tightening wire 30 is used for anchoring.
  • the threading structure 12 of the first anchoring assembly (such as the anchoring assembly 10a in Figure 2) that enters the heart tissue (i.e. the mitral valve annulus 1) is connected, and the other parts of the tightening wire 30 slide through for anchoring into the heart
  • the threading structure 12 of the other anchoring assembly 10 of the tissue is connected to the first anchoring assembly (such as the anchoring assembly 10a in Figure 2) that enters the heart tissue (i.e. the mitral valve annulus 1) is connected, and the other parts of the tightening wire 30 slide through for anchoring into the heart
  • the threading structure 12 of the other anchoring assembly 10 of the tissue is connected to the first anchoring assembly (such as the anchoring assembly 10a in Figure 2) that enters the heart tissue (i.e. the mitral valve annulus 1) is connected, and the other parts of the tightening wire 30 slide through for
  • the anchor 11 includes a nail base 111 and a helical nail 112 fixedly connected to the distal end of the nail base 111 .
  • the nail seat 111 is used for connecting with external instruments, so as to deliver the anchor assembly 10 to the mitral annulus 1 (as shown in FIG. 2 ).
  • the helical nail 112 is used for anchoring into heart tissues such as the mitral annulus 1 .
  • the tip of the distal end of the helical nail 112 can penetrate into the mitral annulus 1 , and the helical nail 112 is driven to rotate by rotating the nail seat 111 to be anchored into the mitral annulus 1 .
  • the part where the anchor 11 is anchored into the heart tissue is exemplified as a helical nail, in other embodiments, it may have another suitable configuration that enables the anchor 11 to engage with the heart tissue and be substantially fixed to the heart tissue. , such as but not limited to barbs, hooks, tines, etc.
  • the distal end of the tightening wire 30 can realize the connection with the first anchoring component (as shown in FIG. Connection of the threading structure 12 of the anchor assembly 10a).
  • the threading structure 12 includes a threading ring 121 and a connecting piece 122, the connecting piece 122 is movably sleeved on the anchor 11, the threading ring 121 is movably connected to the connecting piece 122, and the threading ring 121 is used to connect the tightening wire 30 ( as shown in picture 2).
  • the connecting member 122 is sleeved on the nail base 111 and can rotate relative to the central axis of the nail base 111 . Because the connecting piece 122 can rotate relative to the central axis of the nail seat 111, when the screw 112 rotates with the nail seat 111 and is anchored in the mitral valve annulus 1 (as shown in FIG.
  • the tightening wire 30 winds around the anchor 11 with the rotation of the nail seat 111 , thereby affecting the anchoring of the anchor 11 into the mitral annulus 1 .
  • the connecting piece 122 can rotate around the central axis of the nail seat 111, and the threading ring 121 can move relative to the connecting piece 122, so a plurality of anchoring assemblies 10 anchored into the mitral annulus 1 are respectively connected and tightened through the threading ring 121
  • the threading ring 121 of the anchor assembly 10 can move to the state after the tightening thread 30 is tightened under the action of the pulling force of the tightening thread 30, each anchor
  • the threading ring 121 of the assembly 10 can be moved so that the threading direction is along the circumferential direction of the mitral annulus 1, thereby greatly reducing the resistance of the tightening wire 30 during tightening, and the tightening wire 30 has no bending
  • the situation and the tightening is stable and smooth, so that
  • the pulling force is reduced and the force distributed by the pulling force on each anchor component 10 is more uniform, so that each anchor component
  • the pulling force of 10 is greatly reduced, reducing the force of each anchoring component 10 on the mitral valve annulus 1, reducing the risk of damage to the mitral valve annulus 1, while avoiding the occurrence of a single anchoring component
  • the fact that the pulling force on 10 is relatively large reduces the risk of the anchoring component 10 falling off, and the implantation is safer.
  • the threading structure 12 may be a threading ring 121 movably sleeved on the anchor 11 .
  • the threading ring 121 is movably sleeved on the nail seat 111 of the anchor 11; of course, the threading ring 121 can also be movably sleeved on the screw 112 of the anchor 11 to ensure that the threading ring 121 does not fall off from the anchor 11 just drop.
  • the threading structure 12 can also be a perforation provided on the nail base 111 , the central axis of the perforation is perpendicular to the central axis of the nail base 111 , and the anchor assembly 10 is mounted on the tightening wire 30 through the perforation.
  • the implant 100 further includes a wire retractor 40, and the wire retractor 40 includes a housing 41 and a coil rotatably arranged in the housing 41. Spool 42.
  • the tightening wire 30 moves through the housing 41 and the winding shaft 42 , and the winding shaft 42 rotates relative to the housing 41 to wind the tightening wire 30 .
  • the tightening wire 30 is locked in the radial space 43 between the winding shaft 42 and the casing 41 .
  • the tightening wire 30 By controlling the winding shaft 42 to rotate relative to the casing 41, the tightening wire 30 can be wound, so that the tightening wire 30 is continuously tightened to shrink the mitral valve annulus 1 until the mitral valve regurgitation weakens or disappears. Rotate the bobbin 42, at this time the tightening wire 30 is locked in the radial space 43 between the bobbin 42 and the housing 41, and the tightening wire 30 maintains a certain length on the mitral annulus 1. It can be understood that the locking effect of the tightening wire 30 is good when the mitral annulus 1 is retracted by winding and locking the tightening wire 30 with the wire retractor 40 .
  • the wire take-up device 40 can be directly controlled to further coil the tightening wire 30 to reduce the valve annulus so that the regurgitation weakens or disappears, avoiding two The operation caused great harm to the patient.
  • the wire take-up 40 can be made of 316L stainless steel, or other biocompatible materials, which is not limited in this application.
  • the tightening wire 30 is wound at least three times on the winding shaft 42, and the frictional force between the tightening wire 30 and the winding shaft 42 can offset the pulling force generated by the movement of the mitral valve leaflets, ensuring that the tightening wire 30 Not pulled by the pulling force created by leaflet activity.
  • the wire take-up 40 also includes a limiting post 44 , a rotation stop wheel 45 and an elastic member 46 .
  • the housing 41 includes a bottom shell 411 and an outer shell 412 , the proximal end and the distal end of the shell 412 are open, and the bottom shell 411 is fixedly connected to the distal end of the shell 412 to form an installation space 413 .
  • the installation space 413 is used for accommodating the winding shaft 42 , the limiting post 44 , the anti-rotation wheel 45 and the elastic member 46 .
  • the winding shaft 42 is provided with a through hole 421 along its radial direction
  • the shell 412 is provided with two wire holes 4121 on both sides of the winding shaft 42 , and the two wire holes 4121 are connected to the through hole 421 of the winding shaft 42 .
  • the tightening wire 30 first passes through a wire hole 4121 into the installation space 413 of the housing 41, then passes through the through hole 421 of the bobbin 42, and then passes through another wire hole 4121.
  • a wire hole 4121 passes through the casing 41 .
  • the central axis of the two wire holes 4121 is in the same plane as the central axis of the through hole 421, and the rotatable bobbin 42 makes the central axis of the through hole 421 collinear with the central axis of the two wire holes 4121, which is conducive to the collection
  • the tight wire 30 passes through the two wire holes 4121 and the through hole 421 smoothly.
  • the distal end of the limiting post 44 is fixedly connected to the bottom case 411 , and the anti-rotation wheel 45 is sheathed on the limiting post 44 and can move axially along the limiting post 44 .
  • the near-end surface of the anti-rotation wheel 45 is provided with some first helical teeth 451 along the circumferential ring
  • the far-end surface of the winding shaft 42 is provided with some second helical teeth 422 along the circumferential ring
  • the winding shaft 42 is sleeved on the limit post 44, so that the second The helical tooth 422 can cooperate with the first helical tooth 451 to rotate in one direction.
  • the elastic member 46 is located between the anti-rotation wheel 45 and the bottom shell 411, one end is against the bottom case 411, and the other end is against the anti-rotation wheel 45.
  • a helical tooth 451 engages with the second helical tooth 422 of the winding shaft 42 .
  • the second helical tooth 422 When the bobbin 42 rotated forward, the second helical tooth 422 slipped on the first helical tooth 451 to make the anti-rotation wheel 45 move to the far end. The rotating wheel 45 will move proximally after receiving the elastic force given by the elastic member 46 , so that the first helical teeth 451 and the second helical teeth 422 are reattached, and the bobbin 42 can continue to rotate relative to the stop wheel 45 .
  • the second helical tooth 422 cannot move the anti-rotation wheel 45 to the distal end, and the second helical tooth 422 cannot pass over any one of the first helical teeth 451 so that the bobbin 42 cannot reverse.
  • the take-up wire 30 can be locked in the radial space 43 between the winding shaft 42 and the casing 41 .
  • the radial space 43 refers to the space formed by the winding shaft 42 and the casing 412 , and the radial space 43 is a part of the installation space 413 .
  • the far end surface of the bobbin 42 is also provided with a groove 423 that cooperates with the proximal end of the limit post 44.
  • the proximal surface of the limit post 44 contacts the far end surface of the bobbin 42, and the proximal end of the housing 412 jointly limits the winding.
  • the axial displacement of the bobbin 42 in the installation space 413 makes the bobbin 42 only rotatable.
  • the near-end of the anti-rotation wheel 45 is also provided with a limiting boss 452, and the far-end of the shell 412 is provided with a limiting groove, and the limiting boss 452 is stuck in the limiting groove, which can limit the rotation of the anti-rotating wheel 45, so that the anti-rotating wheel 45 It can only move along the axial direction of the limit post 44 .
  • the tightening wire 30 is pulled to shrink the annulus to weaken mitral valve regurgitation. Or after disappearing, can send into lock nail (not shown in the figure) along the tightening line 30 and lock the tightening line 30 after tightening, make the tightening line 30 keep the state after tightening, the tightening line 30 is superfluous The part can be cut out.
  • the embodiment of the present application also provides a transcatheter cardiac repair system 1000 , which includes a delivery device 200 , an anchoring device 300 and the aforementioned implant 100 .
  • the delivery device 200 includes a delivery sheath 201, the anchoring device 300 is movably worn in the lumen 2011 of the delivery sheath 201, the anchor assembly 10 is worn in the distal end lumen of the delivery sheath 201, and the anchor assembly 10 and The distal end of the anchoring device 300 is detachably connected.
  • the delivery sheath 201 is used to deliver the anchor assembly 10 to the heart tissue (ie, the mitral annulus 1 ), and the anchor device 300 is used to drive the anchor assembly 10 to anchor into the heart tissue.
  • the anchoring device 300 and the anchoring assembly 10 need to be inserted into the lumen 2011 of the delivery sheath 201 first.
  • the distal end of the anchoring device 300 can be passed through the distal end of the delivery sheath 201 along the lumen 2011 of the delivery sheath 201, and then the anchor assembly 10 is connected with the anchoring device 300, and the The anchoring device 300 is withdrawn until the anchoring assembly 10 is worn in the distal lumen of the delivery sheath 201 .
  • the delivery sheath 201 is pushed to deliver the anchoring device 300 and the anchoring assembly 10 to the annulus 1 of the mitral valve, and the anchoring device 300 drives the anchoring assembly 10 to be anchored into the annulus 1 of the mitral valve.
  • the lumen 2011 of the delivery sheath 201 runs through the two opposite ends of the delivery sheath 201 along the axial direction, and the distal lumen refers to the space where the lumen 2011 is located at the distal end of the delivery sheath 201 .
  • the anchoring device 300 includes a driving tube 301 and a connecting rod 302 mounted in the driving tube 301 , and the proximal end of the anchoring component 10 is provided with a first connecting portion 113 , The distal end of the driving tube 301 is provided with a second connecting part 303 that is detachably connected to the first connecting part 113, and the connecting rod 302 is passed through the first connecting part 1013 and the second connecting part that are mated and connected along the axial direction of the driving tube 301.
  • connection between the driving tube 301 and the anchoring assembly 10 is used to drive the anchoring assembly 10 to anchor into the heart tissue (ie, the mitral annulus 1 as shown in FIG. 3 ).
  • the connection between the driving tube 301 and the anchor assembly 10 can be maintained by the connecting rod 302 passing through the first connecting part 113 and the second connecting part 303, and the driving can be released by withdrawing the connecting rod 302 towards the proximal end.
  • the connection between the pipe 301 and the anchor assembly 10 is easy to operate and easy to assemble and disassemble.
  • the first connecting part 113 is an S-shaped buckle protruding from the proximal end of the nail seat 111 of the anchor 11
  • the second connecting part 303 is an S-shaped buckle protruding from the distal end of the driving tube 301, and the two S Type buckles can be buckled correspondingly.
  • the connecting rod 302 passes through the first connecting part 113 and the second connecting part 303 along the axial direction of the drive tube 301 and presses against the nail base 111. 302 can keep the fastening between the first connecting part 113 and the second connecting part 303 , so that the anchoring assembly 10 and the anchoring device 300 are kept connected.
  • both the driving tube 301 and the connecting rod 302 are made of stainless steel 304V, of course, they can also be made of other materials, which is not limited in this application.
  • the wall of the delivery sheath 201 is provided with a through groove 2012 communicating with its lumen 2011
  • the through groove 2012 is in the shape of a straight line and extends to the delivery sheath along the axial direction of the delivery sheath 201
  • the distal end of the tube 201 , the channel 2012 has an opening at the distal end of the delivery sheath 201 .
  • the threading ring 121 is exposed to the outside of the delivery sheath 201 from the through groove 2012.
  • Such a design facilitates the passage of the tightening wire 30 and facilitates the anchoring assembly 10 to be worn on the tightening wire 30;
  • the tightening wire 30 is located outside the delivery sheath 201, during the process of anchoring the anchor assembly 10 into the mitral annulus 1 (as shown in FIG. 3 ), this can prevent the tightening wire 30 from wrapping around the anchor 11 and avoid affecting the anchor.
  • the opening of the through groove 2012 is provided with chamfers or rounded corners, which facilitates the insertion of the anchor assembly 10 into the through groove 2012, facilitates assembly, and improves operation efficiency.
  • the distal end of the delivery sheath 201 is further provided with a stopper 2013 , and the stopper 2013 is used to close or open the opening of the channel 2012 at the distal end of the delivery sheath 201 .
  • the stopper 2013 is operated to open the opening of the through groove 2012 , so that the threading ring 121 of the anchor assembly 10 can enter the through groove 2012 from the opening.
  • the stopper 2013 is operated to close the opening of the channel 2012, preventing the tightening wire 30 outside the delivery sheath 201 from falling into the delivery channel 2012.
  • the inner cavity 2011 of the sheath tube 201 is entangled with the anchor 11 (as shown in FIG. 21 ).
  • the threading ring 121 of the anchoring assembly 10 cannot slide out from the opening of the through groove 2012 , which also prevents the anchoring assembly 10 from detaching from the delivery sheath 201 during delivery.
  • the delivery device 200 further includes a delivery wire 202 , the distal end of the delivery wire 202 is connected to the proximal end of the tightening wire 30 .
  • a sufficiently long conveying line 202 can be used, and correspondingly, a shorter tightening line 30 can be used.
  • the delivery wire 202 is connected to the tightening wire 30 , and after the first anchoring assembly 10 connected to the distal end of the tightening wire 30 is delivered to the mitral annulus 1 , the delivery wire 202 can be extended outside the human body.
  • the anchor assembly 10 , the spacer 20 , and the wire retractor 40 to be implanted later can be slid on the tightening wire 30 through the delivery wire 202 outside the body. After the implant 100 is implanted and left at the mitral annulus 1, the delivery wire 202 can be disconnected from the tightening wire 30, and the delivery wire 202 can be taken out from the human body.
  • the tightening wire 30 has a certain axial length and is flexible, and the radial cross-sectional shape of the tightening wire 30 can be circular, oblate, rectangular, square or other shapes; With a certain axial length and flexibility, the radial cross-sectional shape of the conveying line 202 can also be circular, oblate, rectangular, square or other shapes; The shape is not specifically limited.
  • the delivery device 200 omits the delivery wire 202, the length of the cinch wire 30 is long enough to extend outside the patient's body.
  • the transcatheter cardiac repair system 1000 further includes an introducing sheath 500 .
  • the guide sheath 500 is used to establish an intervention channel from the outside of the patient's body to the mitral valve annulus 1 (as shown in FIG. As shown in Figure 26) to the mitral annulus 1.
  • FIG. 18 the transcatheter cardiac repair system 1000 further includes an introducing sheath 500 .
  • the guide sheath 500 is used to establish an intervention channel from the outside of the patient's body to the mitral valve annulus 1 (as shown in FIG. As shown in Figure 26) to the mitral annulus 1.
  • the transcatheter cardiac repair system 1000 includes two guiding sheaths 500 , which are respectively a first guiding sheath 501 and a second guiding sheath worn in the first guiding sheath 501 502, the second guide sheath 502 can protrude from the distal end of the first guide sheath 501 and fit on the mitral valve annulus 1, thereby establishing an intervention channel from the outside of the human body to the mitral valve annulus 1 .
  • both the first guiding sheath 501 and the second guiding sheath 502 are adjustable curved sheaths, so that the bending angle and direction of the distal end of the guiding sheath 500 can be better adjusted, which in turn facilitates the introduction of the guiding sheath.
  • the distal end of the tube 500 is adjusted to fit the angle of the mitral annulus 1 .
  • only one adjustable bendable guiding sheath 500 may also be used.
  • the adjustable sheath tube is a commonly used guide device in interventional surgery in the prior art, and will not be described in detail here.
  • the transcatheter cardiac repair system 1000 further includes a push rod 600 , the distal end of the push rod 600 is provided with a guide hole 601 , and after the spacer 20 is worn on the delivery wire 202 , the delivery line 202 moves through the guide hole 601, the push rod 600 pushes the spacer 20 along the delivery line 202 and enters the guide sheath 500, and the delivery sheath 201 is movably worn in the guide sheath 500 so that the guide sheath The spacer 20 is pushed in the tube 500 so that the spacer 20 is threaded on the take-up line 30 along the delivery line 202 .
  • the delivery sheath 201 and the anchoring device 300 are withdrawn.
  • the part 20 can be worn outside the body on the delivery line 202, the proximal end of the delivery line 202 passes through the guide hole 601 of the push rod 600, and the push rod 600 can push the spacer 20 into the guide sheath 500 along the delivery line 202 .
  • the push rod 600 is taken out, and the second anchor assembly 10 installed in the delivery sheath tube 201 is threaded on the delivery line 202 through the threading ring 121 exposed outside the delivery sheath tube 201, and the delivery sheath tube 201 is further threaded.
  • the spacer 20 is located on the distal side of the delivery sheath 201 .
  • the delivery sheath 201 moves axially and distally in the guide sheath 500, so that the spacer 20 and the anchor assembly 10 can be threaded on the tightening wire 30 along the delivery line 202, and the spacer 20 is pushed to the mitral annulus 1, and then the anchoring device 300 pushes the second anchor assembly 10 out of the delivery sheath 201 and anchors the second anchor assembly 10 into the mitral annulus 1, so that the spacer 20 is located between the two anchor assemblies 10 .
  • the same steps are repeated, and multiple anchor assemblies 10 are implanted into the mitral valve annulus 1 sequentially, while multiple spacers 20 are sequentially inserted between every two anchor assemblies 10 .
  • the transcatheter heart repair system 1000 further includes an adjustment tool 400, the wire retractor 40 is detachably connected to the distal end of the adjustment tool 400, and the adjustment tool 400 is used to drive the wire retractor 40 tightens up the tightening line 30 (as shown in Figure 15).
  • the adjustment tool 400 includes an outer sheath tube 401 , a rotating tube 402 and a threaded rod 403 that are sheathed sequentially from outside to inside.
  • the outer sheath tube 401 is connected with the housing 41 of the wire take-up 40 to limit the rotation of the housing 41, the rotating tube 402 is clamped with the proximal end of the winding shaft 42, and the threaded rod 403 is screwed with the winding shaft 42 to press the rotating tube 402 so that The rotating tube 402 remains connected to the bobbin 42 . Therefore, the winding shaft 42 can be driven to rotate by rotating the rotating tube 402 to wind the tightening wire 30 to tighten the tightening wire 30 .
  • the shell 412 of the housing 41 is provided with a slot 4122, and the distal end of the outer sheath tube 401 is provided with a claw 4011 corresponding to the slot 4122.
  • the outer sheath The pipe 401 is connected with the casing 41 .
  • the proximal end of the bobbin 42 protrudes from the proximal opening of the housing 412 , and the proximal end of the bobbin 42 is provided with a threaded hole 424 along its axial direction.
  • a first boss 4021 protrudes from the inner wall of the rotating tube 402
  • a second boss 4031 protrudes from the outer wall of the threaded rod 403 .
  • the threaded rod 403 is screwed with the threaded hole 424, that is, the threaded rod 403 is screwed with the winding shaft 42, so that the first boss 4021 presses against the winding shaft 42 and the second boss 4031 Between, the rotating tube 402 is kept connected with the winding shaft 42 .
  • the outer sheath tube 401 restricts the rotation of the housing 41, and the rotation of the rotating tube 402 can drive the threaded rod 403 and the bobbin 42 to rotate synchronously, so that the bobbin 42 rotates relative to the casing 41 to wind the tightening wire 30 (as shown in Figure 15 shown) and the tightening line 30 is tightened.
  • the anchoring device 300 is worn in the delivery sheath 201 and passed out from the distal end of the delivery sheath 201 to connect with the first anchoring assembly 10; then, the anchoring device 300 is withdrawn toward the proximal end , driving the first anchoring assembly 10 into the delivery sheath 201, at this time, the threading ring 121 of the first anchoring assembly 10 is exposed to the outside of the delivery sheath 201 from the through groove 2012, and the threading ring 121 connected with The tightening line 30 and the delivery line 202 connected with the tightening line 30 are located outside the delivery sheath tube 201; then, the delivery sheath tube 201 is pushed into the guide sheath tube 500 and delivered along the guide sheath tube 500 until the first The anchoring assembly 10 is delivered to the vicinity of the mitral
  • the second anchor assembly 10 has been connected to the distal end of the anchoring device 300 and is located in the delivery sheath 201) and in the guide sheath 500 towards Push the delivery sheath 201 distally (L3 direction as shown in FIG. 27 ), and through the pushing of the delivery sheath 201, the first spacer 20 and the second anchor assembly 10 are worn along the delivery line 202 and tightened. Wire 30 and delivered to the mitral valve annulus 1 (as shown in FIG. 28 ); finally, the second anchor assembly 10 is anchored into the mitral valve annulus 1 .
  • step S4 Repeat step S3. As shown in FIG. 28, the rest of the spacer 20 and the anchor assembly 10 are driven into the posterior triangle from the anterior triangle of the mitral annulus 1 along its posterior annulus (or with it) opposite direction), so that the anchoring assemblies 10 and the spacers 20 are alternately and evenly distributed on the mitral annulus 1, wherein each spacer 20 is located between every two anchoring assemblies 10.
  • the tightening line 30 is locked on the spool 42 and the radial space 43 between the housing 41, the tightening wire 30 maintains a certain length on the mitral valve annulus 1; finally, the connection between the adjustment tool 400 and the wire retractor 40 and the connection between the delivery wire 202 and the retractor 40 are released. Tighten the connection of the wire 30, withdraw the adjustment tool 400, the delivery wire 202 and the guide sheath 500 from the body, and leave the wire take-up device 40 at the mitral annulus 1 along with the tightening wire 30, so as to shrink the ring so that the two The goal of treatment is the reduction or disappearance of cusp regurgitation.
  • the implant 100 in addition to being directly implanted on the valve annulus (mitral valve annulus 1, tricuspid valve annulus) on the side of the atrium, the implant 100 can also be implanted under the valve annulus, that is, the implant 100 can also be implanted into the wall of the left ventricle below the mitral annulus or the wall of the right ventricle below the tricuspid annulus. Wherein, implanting the implant 100 on the wall of the left ventricle is especially suitable for treating heart failure and functional mitral regurgitation caused by abnormal function of the left ventricle.
  • the guide sheath 500 can be punctured from the femoral artery, retrogradely enters the left ventricle through the aortic valve, and the implant 100 is implanted on the wall of the left ventricle through the delivery device 200 and the anchoring device 300, and the tightening wire 30 is tightened and directly
  • the reduction of the mitral valve annulus is achieved by inhibiting the expansion of the left ventricle.
  • This subannular annulus can preserve the natural structure of the mitral valve. That is to say, the transcatheter heart repair system 1000 of the present application is not only used for shrinking the valve ring during annuloplasty, but also can be used for reducing the volume of the ventricle during ventricular volume reduction.
  • the use process of valve annuloplasty is basically similar and will not be repeated here.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

An implant (100) capable of accelerating endothelialization and a transcatheter cardiac repair system. The implant (100) comprises a plurality of anchoring assemblies (10), a plurality of spacers (20), and a tightening wire (30). The anchoring assemblies (10) are used for anchoring into cardiac tissue. The spacers (20) have elasticity in axial directions thereof. The plurality of anchoring assemblies (10) and the plurality of spacers (20) are alternately penetratingly mounted on the tightening wire (30), and a distal end of the tightening wire (30) is connected to a first anchoring assembly (10) that is used for anchoring into the cardiac tissue. In the implant (100), when the first anchoring assembly (10) thereof is anchored into the cardiac tissue, the other anchoring assemblies (10) and the plurality of spacers (20) can be delivered to the cardiac tissue along the tightening wire (30) that is connected to the first anchoring assembly (10). After the anchoring assemblies (10) are all anchored into the cardiac tissue, all of the spacers (20) and all of the anchoring assemblies (10) can be brought into close proximity along the tightening wire (30) by means of pulling the tightening wire (30), each of the spacers (20) and the adjacent anchoring assemblies (10) thereof being pressed to be compressed in an axial direction. Thus, when the implant (100) is implanted into the cardiac tissue, gaps between the anchoring assemblies (10) and the spacers (20) are eliminated.

Description

可加速内皮化的植入物及经导管心脏修复系统Implants and transcatheter cardiac repair systems that accelerate endothelialization
本申请要求于2021年12月31日提交至中国专利局、申请号为202111671786.6、申请名称为“可加速内皮化的植入物及经导管心脏修复系统”的中国专利申请的优先权,其全部内容通过引用结合在本申请中。This application claims the priority of the Chinese patent application with the application number 202111671786.6 and the title of “Endothelialization Accelerated Implant and Transcatheter Cardiac Repair System” submitted to the China Patent Office on December 31, 2021, all of which The contents are incorporated by reference in this application.
技术领域technical field
本申请涉及医疗器械技术领域,尤其涉及一种可加速内皮化的植入物及经导管心脏修复系统。The present application relates to the technical field of medical devices, in particular to an implant capable of accelerating endothelialization and a transcatheter heart repair system.
背景技术Background technique
二尖瓣反流(简称:MR)是一种常见的心脏瓣膜疾病,包括原发性二尖瓣反流和继发性二尖瓣反流。原发性二尖瓣反流是由于二尖瓣瓣叶异常、腱索断裂或乳头肌功能不全导致二尖瓣前后叶吻合不良,而造成血液反流;继发性二尖瓣反流是由于瓣环扩张、左心房及左心室扩大导致二尖瓣前后叶吻合不良,而造成血液反流。因此,可通过器械对二尖瓣瓣环进行缩环或对左心室进行缩窄以减轻继发性二尖瓣反流。Mitral regurgitation (abbreviation: MR) is a common heart valve disease, including primary mitral regurgitation and secondary mitral regurgitation. Primary mitral regurgitation is due to abnormal mitral valve leaflets, chordal rupture or papillary muscle insufficiency leading to poor anastomosis of the anterior and posterior leaflets of the mitral valve, resulting in blood regurgitation; secondary mitral regurgitation is due to Annulus expansion, left atrium and left ventricle enlargement lead to poor anastomosis of the anterior and posterior leaflets of the mitral valve, resulting in blood regurgitation. Therefore, the mitral annulus can be constricted or the left ventricle can be narrowed to reduce secondary mitral regurgitation.
现有技术公开了一种经导管左心室修复系统,如图1所示,其在一丝线1a上交替穿装有若干锚钉1b和若干间隔件1c,其中,每个锚钉1b可植入左心室壁1d。每个锚钉1c植入左心室壁1d后,再朝近端牵拉丝线1a(如图1中的L0方向),若干间隔件1c以及植入左心室壁1d的若干锚钉1b沿丝线1a相互靠近而实现对左心室的收缩,进而对二尖瓣反流治疗。The prior art discloses a transcatheter left ventricular repair system, as shown in Figure 1, which alternately wears several anchors 1b and several spacers 1c on a thread 1a, wherein each anchor 1b can be implanted Left ventricular wall 1d. After each anchor 1c is implanted in the left ventricle wall 1d, the silk thread 1a is pulled toward the proximal end (as shown in the L0 direction in Figure 1), and several spacers 1c and several anchors 1b implanted in the left ventricle wall 1d are along the silk thread 1a. Close to each other to achieve the contraction of the left ventricle, and then treat mitral regurgitation.
然而,在将锚钉1b植入左心室壁1d的过程中,相邻锚钉1b植入时的间距难以保证均匀,且无法确保每个植入左心室壁1d的锚钉1b的中轴线均相对于左心室壁1d垂直;而且,在朝近端牵拉丝线1a以对左心室收缩的过程中,若干植入左心室壁1d的锚钉1a会相对左心室壁1d倾斜而沿丝线1a相互靠近,相邻锚钉1b之间的间距更难以确保相同。这样,当朝近端牵拉丝线1a以对左心室进行缩窄时,导致部分间隔件1c存在一个端面甚至两个端面没有和锚钉1b贴合,锚钉1b和间隔件1c之间存在一定间隙而导致内皮化的时间延长,增加手术后期的风险。However, in the process of implanting the anchor 1b into the left ventricle wall 1d, it is difficult to ensure that the distance between adjacent anchors 1b is uniform, and it is impossible to ensure that the central axis of each anchor 1b implanted in the left ventricle wall 1d is uniform. Perpendicular to the left ventricular wall 1d; and, during the process of pulling the wire 1a proximally to contract the left ventricle, several anchors 1a implanted in the left ventricular wall 1d will be inclined relative to the left ventricular wall 1d and mutually along the wire 1a Closer, the spacing between adjacent anchors 1b is more difficult to ensure the same. In this way, when the wire 1a is pulled toward the proximal end to constrict the left ventricle, one end surface or even two end surfaces of part of the spacer 1c do not fit with the anchor 1b, and there is a certain gap between the anchor 1b and the spacer 1c. Gaps lead to prolonged endothelialization time, increasing the risk of postoperative period.
发明内容Contents of the invention
为了解决上述技术问题,本申请提供了一种可加速内皮化的植入物及经导管心脏修复系统。In order to solve the above technical problems, the present application provides an implant that can accelerate endothelialization and a transcatheter heart repair system.
本申请首先提供了一种可加速内皮化的植入物,其包括多个锚定组件、多个间隔件以及收紧线。锚定组件用于锚入心脏组织。间隔件在其轴向上具有弹性。多个锚定组件与多个间隔件交替穿装于收紧线上,收紧线的远端与用于锚入心脏组织的第一个锚定组件连接。The present application firstly provides an implant capable of accelerating endothelialization, which includes multiple anchor components, multiple spacers and tightening wires. An anchor assembly is used to anchor into cardiac tissue. The spacer is elastic in its axial direction. A plurality of anchor components and a plurality of spacers are alternately worn on the tightening wire, and the distal end of the tightening wire is connected with the first anchor component for anchoring into the heart tissue.
上述可加速内皮化的植入物,当其第一个锚定组件锚入心脏组织时,其他锚定组件与多个间隔件可沿与第一个锚定组件连接的收紧线输送至心脏组织处。当每个锚定组件都锚入心脏组织后,通过收紧收紧线,可使交替分布的间隔件以及锚定组件沿收紧线相互靠近,通过缩小多个锚定组件之间的间距进而对瓣环进行缩环或对心室进行缩窄以减轻血液反流。由于每一个间隔件在其轴向上具有弹性,每一个间隔件被与其相邻的两个锚定组件挤压而沿轴向压缩,使每一个间隔件沿其轴向的端面与和其相邻的锚定组件贴合,消除了锚定组件与间隔件之间的间隙,可加速植入物植入心脏组织后的内皮化,降低了手术后期的风险。The above-mentioned implant that can accelerate endothelialization, when the first anchoring component is anchored into the heart tissue, other anchoring components and multiple spacers can be delivered to the heart along the tightening wire connected to the first anchoring component organization office. After each anchoring component is anchored into the heart tissue, by tightening the tightening wire, the alternately distributed spacers and anchoring components can be made close to each other along the tightening wire, and the space between multiple anchoring components can be narrowed to further Restriction of the annulus or narrowing of the ventricles to reduce backflow of blood. Since each spacer has elasticity in its axial direction, each spacer is squeezed and compressed in the axial direction by the two anchor components adjacent to it, so that the end surface of each spacer along its axial direction is in line with its corresponding Adjacent anchoring components fit together, eliminating the gap between the anchoring component and the spacer, accelerating the endothelialization of the implant after it is implanted into the heart tissue, and reducing the risk in the later stage of the operation.
本申请还提供了一种经导管心脏修复系统,其包括输送装置、锚定装置及上述可加速内皮化的植入物。输送装置包括输送鞘管。锚定装置活动穿装于输送鞘管的内腔中,锚定组件穿装于输送鞘管的远端内腔中,锚定组件与锚定装置的远端可拆卸连接,输送鞘管用于将锚定组件输送至心脏组织处,锚定装置用于驱动锚定组件锚入心脏组织。The present application also provides a transcatheter heart repair system, which includes a delivery device, an anchoring device and the above-mentioned implant capable of accelerating endothelialization. The delivery device includes a delivery sheath. The anchoring device is movably installed in the lumen of the delivery sheath, the anchoring assembly is installed in the distal end of the delivery sheath, the anchoring assembly is detachably connected to the distal end of the anchoring device, and the delivery sheath is used to The anchor component is delivered to the heart tissue, and the anchor device is used to drive the anchor component to anchor into the heart tissue.
附图说明Description of drawings
为了更清楚地说明本申请实施方式的技术方案,下面将对实施方式中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图是本申请一些实施方式,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其它的附图。In order to more clearly illustrate the technical solutions of the embodiments of the present application, the following will briefly introduce the drawings that need to be used in the embodiments. Apparently, the drawings in the following description are some embodiments of the present application, which are common to those skilled in the art. Technical personnel can also obtain other drawings based on these drawings without paying creative work.
图1是现有技术提供的经导管左心室修复系统对左心室进行缩窄的结构示意图。Fig. 1 is a schematic diagram of the structure of the left ventricle narrowed by the transcatheter left ventricle repair system provided by the prior art.
图2是本申请实施方式提供的植入物的结构示意图。Fig. 2 is a schematic structural view of the implant provided in the embodiment of the present application.
图3是本申请实施方式提供的植入物处于收紧状态下的结构示意图。Fig. 3 is a schematic structural view of the implant provided in the embodiment of the present application in a tightened state.
图4是图3中的间隔件(省略覆膜)处于自然状态下的结构示意图。FIG. 4 is a schematic structural view of the spacer (with the film omitted) in FIG. 3 in a natural state.
图5是图3中的间隔件处于自然状态下的分解示意图。Fig. 5 is an exploded schematic view of the spacer in Fig. 3 in a natural state.
图6是图5中的间隔件组装后沿其轴向剖切的剖视图。Fig. 6 is a cross-sectional view of the spacer in Fig. 5 after being assembled along its axial direction.
图7是图3中的间隔件(省略覆膜)处于完全压缩状态下的结构示意图。FIG. 7 is a schematic structural view of the spacer (with the film omitted) in FIG. 3 in a fully compressed state.
图8是图3中VIII部分的放大图。FIG. 8 is an enlarged view of part VIII in FIG. 3 .
图9是图3中的间隔件(省略覆膜)处于未完全压缩状态下的结构示意图。FIG. 9 is a schematic structural view of the spacer (with the film omitted) in FIG. 3 in an incompletely compressed state.
图10是图3中X部分的放大图。Fig. 10 is an enlarged view of part X in Fig. 3 .
图11是图3中的间隔件(省略覆膜)处于自然状态下的另一实施方式的结构示意图。FIG. 11 is a schematic structural view of another embodiment of the spacer (with the film omitted) in FIG. 3 in a natural state.
图12是图11中的间隔件处于压缩状态下的结构示意图。Fig. 12 is a schematic structural view of the spacer in Fig. 11 in a compressed state.
图13是图3中的锚定组件的结构示意图。Fig. 13 is a structural schematic diagram of the anchor assembly in Fig. 3 .
图14是图3中的收线器的结构示意图。Fig. 14 is a schematic structural diagram of the wire take-up in Fig. 3 .
图15是图14中的收线器与收紧线配合后沿XV-XV剖切的结构示意图。Fig. 15 is a structural schematic diagram of the section along XV-XV after the wire take-up in Fig. 14 cooperates with the tightening wire.
图16是图14中的收线器(省略外壳)的结构示意图。Fig. 16 is a schematic structural view of the wire take-up (with the shell omitted) in Fig. 14 .
图17是图14中的收线器与调节工具组装后的部分剖视图。Fig. 17 is a partial cross-sectional view of the wire take-up and the adjustment tool in Fig. 14 assembled.
图18是本申请实施方式提供的经导管心脏修复系统的部分结构示意图。Fig. 18 is a partial structural schematic diagram of a transcatheter heart repair system provided by an embodiment of the present application.
图19是本申请实施方式提供的的锚定装置与锚定组件组装后的结构示意图。Fig. 19 is a schematic structural view of the assembled anchoring device and anchoring assembly provided in the embodiment of the present application.
图20是图19的锚定装置与锚定组件分离的示意图。Fig. 20 is a schematic diagram showing the anchoring device of Fig. 19 separated from the anchoring assembly.
图21是图19沿驱动管的中轴线剖切的剖视图。Fig. 21 is a cross-sectional view of Fig. 19 taken along the central axis of the drive tube.
图22是图18中的收紧线、锚定组件、锚定装置与输送鞘管组装后的结构示意图。Fig. 22 is a structural schematic diagram of the assembled tightening wire, anchor assembly, anchor device and delivery sheath in Fig. 18 .
图23至图28是本申请实施方式提供的经导管心脏修复系统应用在二尖瓣瓣环成形术中的使用过程示意图;其中,图24是图23中XXIV部分的放大图。23 to 28 are schematic views of the application process of the transcatheter heart repair system provided by the embodiment of the present application in mitral annuloplasty; wherein, FIG. 24 is an enlarged view of part XXIV in FIG. 23 .
具体实施方式Detailed ways
下面将结合本申请实施方式中的附图,对本申请实施方式中的技术方案进行清楚、完整地描述,显然,所描述的实施方式仅仅是本申请的一部分实施方式,而不是全部的实施方式。基于本申请中的实施方式,本领域普通技术人员在没有付出创造性劳动前提下所获得的所有其它实施方式,都属于本申请保护的范围。The technical solutions in the embodiments of the present application will be clearly and completely described below in conjunction with the accompanying drawings in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the application, not all of them. Based on the implementation manners in this application, all other implementation manners obtained by persons of ordinary skill in the art without making creative efforts belong to the scope of protection of this application.
此外,以下各实施方式的说明是参考附加的图示,用以例示本申请可用以实施的特定实施方式。本申请中所提到的方向用语,例如,“上”、“下”、“前”、“后”、“左”、“右”、“内”、“外”、“侧面”等,仅是参考附加图式的方向,因此,使用的方向用语是为了更好、更清楚地说明及理解本申请,而不是指示或暗指所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本申请的限制。In addition, the following descriptions of the various embodiments refer to the attached drawings to illustrate specific embodiments that the application can be used to implement. The directional terms mentioned in this application, such as "upper", "lower", "front", "rear", "left", "right", "inner", "outer", "side", etc., only is to refer to the direction of the attached drawings. Therefore, the direction terms used are for better and clearer description and understanding of the present application, rather than indicating or implying that the referred device or element must have a specific orientation, and must have a specific orientation. construction and operation, therefore should not be construed as limiting the application.
方位定义:为了描述清晰,以下将手术过程中,靠近操作者的一端称为“近端”,将远离操作者的一端称为“远端”。“部件A”的中轴线指的是“部件A”的几何中心线。“部件A”与“部件B”的连接可以是“部件A”与“部件B”直接接触连接,也可以“部件A”与“部件B”通过“部件C”间接连接。上述定义只是为了表述方便,并不能理解为对本申请的限制。Definition of orientation: For clarity of description, the end close to the operator is referred to as the "proximal end" and the end far away from the operator is referred to as the "distal end" during the operation. The central axis of "part A" refers to the geometric centerline of "part A". The connection between "part A" and "part B" may be a direct contact connection between "part A" and "part B", or an indirect connection between "part A" and "part B" through "part C". The above definitions are only for the convenience of expression, and should not be understood as limitations on the present application.
值得注意的是,无论“近端”、“远端”、“一端”、“另一端”、“第一端”、“第二端”、“初始端”、“末端”、“两端”、“自由端”、“上端”、“下端”等词语中所出现的“端”,并不仅限于端头、端点或端面,也包括自端头、端点、或端面在端头、端点、或端面所属元件上延伸一段轴向距离和/或径向距离的部位。It is worth noting that regardless of "near end", "distal end", "one end", "another end", "first end", "second end", "initial end", "end end", "both ends" , "free end", "upper end", "lower end" and other words, "end" is not limited to the end, end point or end face, but also includes from the end, end point, or end face at the end, end point, or The portion of the element to which the end face belongs extends an axial distance and/or a radial distance.
请参阅图2和图3,本申请实施方式提供了一种可加速内皮化的植入物100,可应用于瓣环成形术或心室减容术,其可植入并留存在二尖瓣瓣环1、三尖瓣瓣环、左心室壁或者右心室壁等心脏组织上,以直接缩小瓣环或者通过缩窄心室使心室减容达到缩小瓣环的目的,从而实现对二尖瓣反流或三尖瓣反流的治疗。另外,对左心室进行减容也可以治疗缺血性心力衰竭。需要说明的是,植入物100植入瓣环或心室壁后一般呈C型或环状。在图2和图3的示例中,心脏组织为二尖瓣瓣环1,为使图示更为直观,二尖瓣瓣环1以直线型示意。为方便描述,下文以心脏组织为二尖瓣瓣环1,植入物100植入并留存在二尖瓣瓣环1上以缩小二尖瓣瓣环1,实现对二尖瓣反流的治疗为例进行具体的说明。Please refer to FIG. 2 and FIG. 3, the embodiment of the present application provides an implant 100 that can accelerate endothelialization, which can be applied to annuloplasty or ventricular volume reduction, and it can be implanted and left in the mitral valve Ring 1, tricuspid valve ring, left ventricle wall or right ventricle wall and other heart tissues, to directly shrink the valve ring or reduce the volume of the ventricle by narrowing the ventricle to achieve the purpose of shrinking the valve ring, so as to achieve mitral regurgitation or tricuspid regurgitation treatment. In addition, volume reduction of the left ventricle can also treat ischemic heart failure. It should be noted that the implant 100 is generally C-shaped or ring-shaped after being implanted in the annulus or the wall of the ventricle. In the examples shown in FIG. 2 and FIG. 3 , the heart tissue is the mitral valve ring 1 , and the mitral valve ring 1 is shown in a straight line to make the illustration more intuitive. For convenience of description, heart tissue is used as the mitral valve annulus 1 below, and the implant 100 is implanted and left on the mitral valve annulus 1 to shrink the mitral valve annulus 1 and realize the treatment of mitral regurgitation Take as an example for specific description.
具体地,植入物100包括多个锚定组件10、多个间隔件20以及收紧线30。锚定组件10用于锚入心脏组织(即二尖瓣瓣环1)。间隔件20在其轴向上具有弹性。多个锚定组件10与多个间隔件20交替穿装于收紧线30上,收紧线30的远端与用于锚入心脏组织的第一个锚定组件10(如图2中的锚定组件10a)连接。在本申请中,间隔件20沿其轴向穿装于收紧线30上。“第一个锚定组件10”指的是多个锚定组件10中按照时间顺序首先输送至心脏组织的锚定组件10,“最后一个锚定组件10”指的是多个锚定组件10中按照时间顺序最后输送至心脏组织的锚定组件10,“第二个锚定组件10”“第三个锚定组件10”等可作类似理解;同理,后文关于“第一个间隔件20”、“第二个间隔件20”、“最后一个间隔件20”等描述可作类似理解。Specifically, the implant 100 includes a plurality of anchor assemblies 10 , a plurality of spacers 20 and tightening wires 30 . The anchoring assembly 10 is used for anchoring into cardiac tissue (ie the mitral valve annulus 1). The spacer 20 has elasticity in its axial direction. A plurality of anchoring assemblies 10 and a plurality of spacers 20 are alternately worn on the tightening wire 30, and the distal end of the tightening wire 30 is connected to the first anchoring assembly 10 for anchoring into the heart tissue (as shown in FIG. 2 ). The anchor assembly 10a) is connected. In this application, the spacer 20 is threaded on the tightening wire 30 along its axial direction. "The first anchor assembly 10" refers to the anchor assembly 10 that is first delivered to the heart tissue in chronological order among the plurality of anchor assemblies 10, and the "last anchor assembly 10" refers to the anchor assembly 10 of the plurality of anchor assemblies 10. Among them, the anchoring components 10 that are finally delivered to the heart tissue in chronological order, "the second anchoring component 10", "the third anchoring component 10" and so on can be understood similarly; 20", "the second spacer 20", "the last spacer 20" and other descriptions can be understood similarly.
上述植入物100,当其第一个锚定组件10锚入二尖瓣瓣环1时,其他锚定组件10与多个间隔件20可沿与第一个锚定组件10连接的收紧线30输送至二尖瓣瓣环1处。当每个锚定组件10都锚入二尖瓣瓣环1后,通过收紧收紧线30,可使交替分布的间隔件20以及锚定组件10沿收紧线30相互靠近,通过缩小多个锚定组件10之间的间距进而对二尖瓣瓣环1进行缩环以减轻血液反流。由于每一个间隔件20在其轴向上具有弹性,每一个间隔件20被与其相邻的两个锚定组件10挤压而沿轴向压缩,使每一个间隔件20沿轴向的端面与其相邻的锚定组件10贴合,消除了锚定组件10与间隔件20之间的间隙,加速植入物100植入二尖瓣瓣环1后的内皮化,降低了手术后期的风险。When the above-mentioned implant 100 is anchored into the mitral valve annulus 1 by its first anchoring component 10, other anchoring components 10 and a plurality of spacers 20 can be tightened along the joint connected to the first anchoring component 10. The wire 30 is delivered to the annulus 1 of the mitral valve. After each anchoring assembly 10 is anchored into the mitral valve annulus 1, by tightening the tightening wire 30, the alternately distributed spacers 20 and anchoring assemblies 10 can be made to approach each other along the tightening wire 30, and by shrinking more The spacing between the two anchoring components 10 further shrinks the mitral annulus 1 to reduce blood regurgitation. Since each spacer 20 has elasticity in its axial direction, each spacer 20 is squeezed by the two anchor assemblies 10 adjacent to it and compressed in the axial direction, so that the end surface of each spacer 20 along the axial direction Adjacent anchoring components 10 fit together, eliminating the gap between the anchoring components 10 and the spacer 20 , accelerating the endothelialization of the implant 100 after it is implanted in the mitral annulus 1 , and reducing the risk in the later stage of the operation.
此外,这样的设计大大降低了对相邻锚定组件10植入时的间距的要求,相邻锚定组件10植入时的间距无需保证均匀,降低了操作难度,有利于提高手术效率。间隔件20可以防止收紧线30过度收紧导致相邻的两个锚定组件10之间的距离过短而损伤二尖瓣瓣环1,同时间隔件20可以起到缓冲作用,分散锚定组件10受到的牵拉力,保证锚定组件10锚入稳定。In addition, such a design greatly reduces the requirement for the distance between adjacent anchor components 10 when they are implanted, and the distance between adjacent anchor components 10 during implantation does not need to be uniform, which reduces the difficulty of operation and is conducive to improving surgical efficiency. The spacer 20 can prevent the excessive tightening of the tightening wire 30 from causing the distance between two adjacent anchoring assemblies 10 to be too short and damage the mitral valve annulus 1. At the same time, the spacer 20 can play a buffer role and disperse the anchoring The pulling force received by the component 10 ensures that the anchor component 10 is anchored stably.
在图2和图3的示例中,锚定组件10的数量仅示出三个,分别为锚定组件10a、锚定组件10b以及锚定组件10c;间隔件20的数量仅示出两个,分别为间隔件20a以及间隔件20b,通常锚定组件10的数量不止三个,间隔件20的数量不止两个。在实际应用中,锚定组件10的数量至少为三个,间隔件20的数量至少为两个,本申请对锚定组件10及间隔件20的数量不作具体的限定。In the examples of FIGS. 2 and 3 , the number of anchor components 10 is only three, which are respectively anchor component 10a, anchor component 10b and anchor component 10c; the number of spacers 20 is only two, They are the spacer 20a and the spacer 20b respectively. Generally, the number of the anchor assembly 10 is more than three, and the number of the spacer 20 is more than two. In practical applications, the number of anchoring components 10 is at least three, and the number of spacers 20 is at least two. The application does not specifically limit the number of anchoring components 10 and spacers 20 .
请参阅图2,锚定组件10a与收紧线30的远端连接,收紧线30的远端随锚定组件10a输送至二尖瓣瓣环1处;当锚定组件10a锚入二尖瓣瓣环1后,间隔件20a自收紧线30的近端穿入并沿收紧线30输送至二尖瓣瓣环1处;然后锚定组件10b自收紧线30的近端穿入并沿收紧线30输送并锚入二尖瓣瓣环1;同理,间隔件20b与锚定组件10c依次输送至二尖瓣瓣环1处,锚定组件10c再锚入二尖瓣瓣环1。然后,通过收紧收紧线30,锚入二尖瓣瓣环1的锚定组件10a、锚定组件10b以及锚定组件10c沿收紧线30相互靠近,就可对二尖瓣瓣环1进行缩环,以减轻二尖瓣反流。Please refer to Fig. 2, the anchoring assembly 10a is connected with the distal end of the tightening wire 30, and the distal end of the tightening wire 30 is delivered to the mitral annulus 1 along with the anchoring assembly 10a; when the anchoring assembly 10a is anchored into the mitral After the valve annulus 1, the spacer 20a is inserted from the proximal end of the tightening wire 30 and delivered to the mitral annulus 1 along the tightening wire 30; then the anchor assembly 10b is inserted from the proximal end of the tightening wire 30 And delivered along the tightening wire 30 and anchored into the mitral annulus 1; similarly, the spacer 20b and the anchoring assembly 10c are delivered to the mitral annulus 1 in sequence, and the anchoring assembly 10c is then anchored into the mitral annulus Ring 1. Then, by tightening the tightening wire 30, the anchoring assembly 10a, the anchoring assembly 10b, and the anchoring assembly 10c anchored into the mitral valve annulus 1 approach each other along the tightening wire 30, and the mitral valve annulus 1 can be tightened. Ring retraction is performed to relieve mitral regurgitation.
请参阅图3,当收紧收紧线30时,锚定组件10a与锚定组件10b相互靠近而挤压间隔件20a,使得间隔件20a沿其轴向被压缩,间隔件20a沿其轴向的相对两端面分别与锚定组件10a及锚定组件10b贴合;锚定组件10b与锚定组件10c相互靠近而挤压间隔件20b,使得第二间隔件21沿其轴向被压缩,间隔件20b沿其轴向的相对两端面分别与锚定组件10b及锚定组件10c贴合。由此消除了锚定组件10与间隔件20之间的间隙,大大加快了内皮化的速度,降低手术后期的风险。Please refer to FIG. 3 , when the tightening wire 30 is tightened, the anchor assembly 10a and the anchor assembly 10b approach each other and squeeze the spacer 20a, so that the spacer 20a is compressed along its axial direction, and the spacer 20a is compressed along its axial direction. The opposite end faces of the anchoring assembly 10a and the anchoring assembly 10b are attached respectively; the anchoring assembly 10b and the anchoring assembly 10c approach each other and press the spacer 20b, so that the second spacer 21 is compressed along its axial direction, and the spacer The opposite ends of the member 20b along the axial direction are attached to the anchoring component 10b and the anchoring component 10c respectively. Thus, the gap between the anchoring assembly 10 and the spacer 20 is eliminated, the speed of endothelialization is greatly accelerated, and the risk in the later stage of the operation is reduced.
在一些实施方式中,间隔件20可以是压缩弹簧。当压缩弹簧沿其轴向被压缩时,压缩弹簧在其轴向上的相对两端面可分别与两个锚定组件10贴合,从而就可消除压缩弹簧与锚定组件10之间的间隙,以减少植入物100内皮化的时间。In some embodiments, spacer 20 may be a compression spring. When the compression spring is compressed along its axial direction, the two opposite end surfaces of the compression spring in the axial direction can be attached to the two anchor assemblies 10 respectively, so that the gap between the compression spring and the anchor assembly 10 can be eliminated, To reduce the time for implant 100 to endothelialize.
请一并参阅图3至图12,在一些实施方式中,间隔件20在其径向上还具有弹性,间隔件20沿其轴向被压缩时,间隔件20沿其径向扩张使间隔件20的外周面与心脏组织(即二尖瓣瓣环1)贴合。可以理解,由于人工操作等不可抗因素,所有锚定组件10锚入二尖瓣瓣环1的深度无法确保全部相同,当收紧收紧线30而对二尖瓣瓣环1进行缩环时,导致部分间隔件20的外周面与二尖瓣瓣环1之间的接触面积较小或无接触,这不利于植入物100的内皮化。在该实施方式中,由于间隔件20在其径向上具有弹性,当收紧收紧线30而对二尖瓣瓣环1进行缩环时,间隔件20在沿其轴向被压缩的同时沿其径向扩张,使得间隔件20的外周面与二尖瓣瓣环1之间具有较大的接触面积,进一步缩短了内皮化的时间,降低手术后期的风险。Please refer to FIGS. 3 to 12 together. In some embodiments, the spacer 20 also has elasticity in its radial direction. When the spacer 20 is compressed along its axial direction, the spacer 20 expands along its radial direction to make the spacer 20 The outer peripheral surface of the valve body is attached to the heart tissue (that is, the mitral valve annulus 1). It can be understood that due to irresistible factors such as manual operation, the anchoring depths of all anchoring components 10 into the mitral annulus 1 cannot be guaranteed to be all the same. When tightening the tightening wire 30 to shrink the mitral annulus , resulting in a small or no contact area between the outer peripheral surface of part of the spacer 20 and the mitral annulus 1 , which is not conducive to the endothelialization of the implant 100 . In this embodiment, since the spacer 20 has elasticity in its radial direction, when the tightening wire 30 is tightened to shrink the mitral valve annulus 1, the spacer 20 is compressed along its axial direction and at the same time The radial expansion makes the outer peripheral surface of the spacer 20 have a larger contact area with the mitral annulus 1, which further shortens the time for endothelialization and reduces the risk in the later stage of the operation.
具体地,间隔件20包括主体部21,主体部21具有轴向内腔211,主体部21采用形状记忆材料制成。主体部21沿其轴向被压缩使主体部21沿其径向扩张。可以理解,间隔件20的轴向与其主体部21的轴向相同,轴向内腔211沿主体部21的轴向贯穿其相对两端面,收紧线30可穿过主体部21的轴向内腔211从而将间隔件20穿装于收紧线30上。这样,当间隔件20沿其轴向被压缩时,即主体部21沿其轴向被压缩而沿其径向扩张,使得间隔件20沿其轴向的端面与其相邻的锚定组件10贴合,同时由于主体部21采用形状记忆材料制成的,主体部21可适应不同结构组织的形状而形变,使得间隔件20的外周面与二尖瓣瓣环1之间具有更大的接触面积,更进一步缩短了内皮化的时间。可选地,形状记忆材料可以是Ti-Ni系形状记忆合金、铜基系形状记忆合金、铁基系形状记忆合金、形状记忆聚合物等,例如镍钛合金,本申请对此不作任何限定。Specifically, the spacer 20 includes a main body 21 having an axial inner cavity 211 , and the main body 21 is made of a shape memory material. The main body portion 21 is compressed in its axial direction so that the main body portion 21 expands in its radial direction. It can be understood that the axial direction of the spacer 20 is the same as the axial direction of the main body 21 , the axial cavity 211 runs through the opposite end surfaces of the main body 21 in the axial direction, and the tightening wire 30 can pass through the axial inner portion of the main body 21 . The lumen 211 thus threads the spacer 20 over the cinch wire 30 . In this way, when the spacer 20 is compressed in the axial direction, that is, the main body 21 is compressed in the axial direction and expands in the radial direction, so that the end surface of the spacer 20 in the axial direction is in close contact with the anchor assembly 10 adjacent to it. At the same time, since the main body 21 is made of shape memory material, the main body 21 can adapt to the shape of different structural tissues and deform, so that there is a larger contact area between the outer peripheral surface of the spacer 20 and the mitral annulus 1 , further shortening the time of endothelialization. Optionally, the shape memory material may be Ti—Ni-based shape memory alloy, copper-based shape-memory alloy, iron-based shape-memory alloy, shape-memory polymer, etc., such as nickel-titanium alloy, which is not limited in this application.
请参阅图4和图11,在一些实施方式中,在自然状态下,主体部21的径向尺寸沿其轴向由中部向两端逐渐减小,换言之,主体部21在其轴向上的中部位置的径向尺寸A1最大。这样,当主体部21沿其轴向被压缩时,主体部21只会沿其径向外部扩张,而不会向内部挤压,保证间隔件20的外周面与二尖瓣瓣环1(如图3所示)之间能稳定地接触。而且,这样的主体部21受力均匀,便于形变。需要说明的是,自然状态指的是,主体部21未受到任何外力作用,即主体部21没有发生形变的状态。Please refer to FIG. 4 and FIG. 11 , in some embodiments, in a natural state, the radial dimension of the main body portion 21 gradually decreases from the middle to both ends along its axial direction, in other words, the axial length of the main body portion 21 The radial dimension A1 at the middle position is the largest. In this way, when the main body portion 21 is compressed along its axial direction, the main body portion 21 will only expand outwardly along its radial direction, and will not be squeezed inward, so as to ensure that the outer peripheral surface of the spacer 20 is in contact with the mitral valve annulus 1 (such as As shown in Figure 3) can be in stable contact. Moreover, such a main body portion 21 is evenly stressed and easy to deform. It should be noted that the natural state refers to the state where the main body 21 is not subjected to any external force, that is, the main body 21 is not deformed.
在图4和图11的示例中,当主体部21处于自然状态时,主体部21为椭圆柱体。可以理解,主体部21也可为椭球体。在其他实施方式中,主体部21也可为细长水滴体,也即是说,当主体部21在自然状态下时,主体部21的径向尺寸两端小,中间大,最大径向尺寸偏离轴向的中部位置。In the examples of FIG. 4 and FIG. 11 , when the main body portion 21 is in a natural state, the main body portion 21 is an elliptical cylinder. It can be understood that the main body 21 can also be an ellipsoid. In other embodiments, the main body 21 can also be an elongated water droplet, that is to say, when the main body 21 is in a natural state, the two ends of the radial dimension of the main body 21 are small, the middle is large, and the maximum radial dimension Off-axis mid-position.
请参阅图3至图12,在一些实施方式中,间隔件20还包括两个固定件22,固定件22沿其轴向设有过线孔221,两个固定件22分别设于主体部21的轴向两端,过线孔221连通轴向内腔211。可以理解,当在收紧线30上穿装间隔件20时,收紧线30依次穿过一个固定件22的过线孔221、主体部21的轴向内腔211以及另一个固定件22的过线孔221。当收紧收紧线30时,与间隔件20相邻的两个锚定组件10相互靠近而抵压两个固定件22,两个固定件22沿主体部21的轴向相互靠近,主体部21被轴向压缩。固定件22的设计,保证主体部21能均匀受力,有利于主体部21形变。Please refer to FIG. 3 to FIG. 12 , in some embodiments, the spacer 20 further includes two fixing pieces 22 , the fixing pieces 22 are provided with a wire passing hole 221 along its axial direction, and the two fixing pieces 22 are respectively arranged on the main body portion 21 The two ends in the axial direction, the wire passing hole 221 communicates with the axial inner chamber 211 . It can be understood that when the spacer 20 is worn on the tightening wire 30, the tightening wire 30 passes through the wire passing hole 221 of one fixing member 22, the axial inner cavity 211 of the main body 21 and the opening of the other fixing member 22 in sequence. Wire hole 221 . When the tightening wire 30 is tightened, the two anchor assemblies 10 adjacent to the spacer 20 approach each other and press the two fixing members 22, and the two fixing members 22 approach each other along the axial direction of the main body portion 21, and the main body portion 21 is axially compressed. The design of the fixing member 22 ensures that the main body 21 can be evenly stressed, which is beneficial to the deformation of the main body 21 .
请参阅图3至图6,在一些实施方式中,间隔件20还包括刚性件23,刚性件23沿其轴向设有穿线孔231,刚性件23收容于轴向内腔211中且位于两个固定件22之间,穿线孔231连通过线孔221。当主体部 21处于自然状态时,刚性件23至少与一固定件22之间沿轴向存在间距。这样,收紧线30沿主体部21的轴向穿过一个固定件22的过线孔221而穿入轴向内腔211中,再穿过穿线孔231自另一个固定件22的过线孔221穿出,就可将间隔件20穿装于收紧线30上。当主体部21处于自然状态时,刚性件23至少与一固定件22之间沿轴向存在间距的设计,保证当收紧收紧线30时,主体部21能沿其轴向被压缩。3 to 6, in some embodiments, the spacer 20 further includes a rigid member 23, the rigid member 23 is provided with a threading hole 231 along its axial direction, the rigid member 23 is accommodated in the axial cavity 211 and is located on both sides. Between the two fixing pieces 22, the threading hole 231 is connected to the threading hole 221. When the main body 21 is in a natural state, there is an axial distance between the rigid part 23 and at least one fixing part 22. In this way, the tightening wire 30 passes through the wire passing hole 221 of one fixing member 22 along the axial direction of the main body portion 21 and penetrates into the axial inner cavity 211, and then passes through the wire passing hole 231 from the wire passing hole of the other fixing member 22. 221, the spacer 20 can be worn on the tightening line 30. When the main body 21 is in a natural state, there is an axial distance between the rigid member 23 and at least one fixing member 22 to ensure that when the tightening wire 30 is tightened, the main body 21 can be compressed in the axial direction.
可以理解,当间隔件20受到轴向作用力时,两个固定件22沿主体部21的轴向相互靠近而抵压刚性件23,主体部21被轴向压缩,刚性件23能限制主体部21的轴向压缩量,从而避免主体部21被过度压缩而挤扁,导致主体部21径向失去弹力。另外,当刚性件23收容于轴向内腔211中时,其可不受限制的活动。在一些示例中,刚性件23为钢管,其内径小于固定件22的外径,其外径大于固定件22的内径,这样当间隔件20受到过大的轴向作用力时,可保证刚性件23始终位于主体部21的轴向内腔211中,且固定件22能稳定地抵压刚性件23。It can be understood that when the spacer 20 is subjected to an axial force, the two fixing members 22 approach each other along the axial direction of the main body 21 and press against the rigid member 23, the main body 21 is axially compressed, and the rigid member 23 can limit the main body. 21, so as to prevent the main body 21 from being over-compressed and crushed, causing the main body 21 to lose its elastic force in the radial direction. In addition, when the rigid member 23 is accommodated in the axial cavity 211, it can move freely. In some examples, the rigid member 23 is a steel pipe with an inner diameter smaller than the outer diameter of the fixing member 22 and an outer diameter larger than the inner diameter of the fixing member 22, so that when the spacer 20 is subjected to excessive axial force, the rigid member can be guaranteed 23 is always located in the axial cavity 211 of the main body 21 , and the fixing part 22 can press the rigid part 23 stably.
请参阅图3至图10,在一些实施方式中,主体部21为网状结构,固定件22包括轴向套设的外套管222及内套管223,所述网状结构的自由端挤压收容于外套管222和内套管223之间。可以理解,网状结构的主体部21具有高弹性和良好的柔顺性,便于形变,这样当主体部21沿径向扩张时,有利于间隔件20的外周面与二尖瓣瓣环1更好地接触而贴合,进一步增大了间隔件20的外周面与二尖瓣瓣环1的接触面积,进一步缩短了内皮化时间。Please refer to Fig. 3 to Fig. 10, in some embodiments, the main body 21 is a mesh structure, the fixing member 22 includes an outer casing 222 and an inner casing 223 sleeved in the axial direction, and the free end of the mesh structure is extruded It is accommodated between the outer sleeve 222 and the inner sleeve 223 . It can be understood that the main body 21 of the mesh structure has high elasticity and good flexibility, and is easy to deform, so that when the main body 21 expands in the radial direction, it is beneficial for the outer peripheral surface of the spacer 20 to better align with the mitral annulus 1. The contact area between the outer peripheral surface of the spacer 20 and the mitral annulus 1 is further increased, and the endothelialization time is further shortened.
具体地,主体部21采用多根镍钛丝编织成网状结构,经热处理后定型,外观呈椭圆柱体。当主体部21热定型时,其轴向两端(即自由端)的镍钛丝向主体部21的轴向内腔211翻折聚合,两端的镍钛丝分别挤压收容于一个固定件22的外套管222和内套管223之间。以其中一端的镍钛丝为例,将其中一端的镍钛丝翻折收拢到一个固定件22的外套管222的管腔224中,然后将内套管223通过过盈挤压的方式沿主体部21的轴向挤压入管腔224中,该端镍钛丝通过其与外套管222及内套管223之间的摩擦力进行固定,从而该端镍钛丝被挤压收容在外套管222的内壁与内套管223的外壁之间。Specifically, the main body 21 is woven into a mesh structure by a plurality of nickel-titanium wires, which is shaped after heat treatment and has an elliptical cylinder appearance. When the main body 21 is heat-set, the nickel-titanium wires at both axial ends (i.e. the free ends) are folded and aggregated toward the axial inner cavity 211 of the main body 21, and the nickel-titanium wires at both ends are squeezed and accommodated in a fixing member 22 respectively. Between the outer casing 222 and the inner casing 223. Taking the nickel-titanium wire at one end as an example, the nickel-titanium wire at one end is folded and gathered into the lumen 224 of the outer sleeve 222 of a fixing member 22, and then the inner sleeve 223 is squeezed along the main body The axial direction of part 21 is squeezed into the lumen 224, and the nickel-titanium wire at the end is fixed by the friction force between it and the outer sleeve 222 and the inner sleeve 223, so that the nickel-titanium wire at the end is squeezed and accommodated in the outer sleeve 222 and the outer wall of the inner sleeve 223.
在该实施方式中,内套管223的管腔即为固定件22的过线孔221,也即是说,当在收紧线30上穿装间隔件20时,收紧线30依次穿过一个固定件22的内套管223的管腔,主体部21的轴向内腔211以及另一个固定件22的内套管223的管腔。外套管222及内套管223的材质均为SUS316Lvm,即二者均为不锈钢管。在其他实施方式中,外套管222及内套管223的材质也可是其他材质,本申请对此不作具体地限定。In this embodiment, the lumen of the inner sleeve 223 is the wire passing hole 221 of the fixing member 22, that is to say, when the spacer 20 is worn on the tightening wire 30, the tightening wire 30 passes through it sequentially. The lumen of the inner sleeve 223 of one fixing member 22 , the axial lumen 211 of the main body 21 and the lumen of the inner sleeve 223 of the other fixing member 22 . The material of the outer casing 222 and the inner casing 223 is SUS316Lvm, that is, both are stainless steel pipes. In other embodiments, the material of the outer sleeve 222 and the inner sleeve 223 may also be other materials, which are not specifically limited in this application.
另外,由于主体部21轴向两端(即自由端)的镍钛丝向主体部21的轴向内腔翻折聚合,固定件22整体位于主体部21的轴向内腔211中,间隔件20沿轴向的两端面为网状的镍钛丝,镍钛丝具有良好的弹力。当间隔件20被轴向压缩时,间隔件20沿轴向的两端面更好地贴合与其相邻的锚定组件10。In addition, since the nickel-titanium wires at the axial ends (i.e., free ends) of the main body 21 are folded and aggregated toward the axial inner cavity of the main body 21, the fixing member 22 is located in the axial inner cavity 211 of the main body 21 as a whole, and the spacer 20 The two ends along the axial direction are meshed nickel-titanium wires, and the nickel-titanium wires have good elasticity. When the spacer 20 is axially compressed, the two ends of the spacer 20 along the axial direction better fit the adjacent anchor assembly 10 .
请参阅图11和图12,在一些实施方式中,主体部21包括多根间隔分布的支撑条212,固定件22为固定管,多根支撑条212围绕固定管22的周向布置。可以理解,在自然状态下,每一支撑条212的中部沿间隔件20的径向向外突出,使得主体部21在其径向上的中部尺寸A1大于其端部尺寸。这样,当间隔件20沿其轴向被挤压时,支撑条212会沿主体部21的径向向外部扩张,有利于间隔件20的外周面与心脏组织(即二尖瓣瓣环1)接触而贴合。另外,由于支撑条212本身的宽度以及厚度比较小,当间隔件20与二尖瓣瓣环1接触而使支撑条212受到径向压力时,支撑条212也能够发生形变而与二尖瓣瓣环1贴合,增大间隔件20与二尖瓣瓣环1的接触面积,有利于进一步缩短内皮化的时间。在图11的示例中,在自然状态下,主体部21呈椭圆柱体。Referring to FIG. 11 and FIG. 12 , in some embodiments, the main body 21 includes a plurality of support bars 212 distributed at intervals, the fixing member 22 is a fixing tube, and the plurality of support bars 212 are arranged around the circumference of the fixing tube 22 . It can be understood that, in a natural state, the middle portion of each support bar 212 protrudes outward along the radial direction of the spacer 20 , so that the radially middle dimension A1 of the main body portion 21 is larger than the end portion thereof. In this way, when the spacer 20 is squeezed along its axial direction, the support bar 212 will expand outward along the radial direction of the main body 21, which is beneficial to the contact between the outer peripheral surface of the spacer 20 and the heart tissue (ie, the mitral valve annulus 1) Touch and fit. In addition, due to the relatively small width and thickness of the support strip 212 itself, when the spacer 20 contacts the mitral valve annulus 1 and the support strip 212 is subjected to radial pressure, the support strip 212 can also be deformed to be in contact with the mitral valve. The fit of the ring 1 increases the contact area between the spacer 20 and the mitral valve ring 1, which is beneficial to further shorten the time for endothelialization. In the example of FIG. 11 , in a natural state, the main body portion 21 is in the shape of an elliptical cylinder.
在一些实施方式中,间隔件20的主体部21及两个固定件22可以采用一根由形状记忆材料制成的管体制成,例如镍钛管。具体地,可对一整段镍钛管进行切割加工,然后将其放置在特定的模具中热定型而成。In some embodiments, the main body 21 and the two fixing members 22 of the spacer 20 can be made of a tube made of a shape memory material, such as a nickel-titanium tube. Specifically, a whole piece of nickel-titanium tube can be cut and processed, and then placed in a specific mold for heat setting.
请参阅图5和图6,在一些实施方式中,间隔件20还包括覆膜24,覆膜24具有弹性,覆膜24包覆于主体部21的外部且与主体部21固定连接。可以理解,由于覆膜24具有弹性,当主体部21沿其轴向被压缩而沿其径向扩张时,包覆在主体部21外部的覆膜24能与形变后的主体部21相适应。覆膜24起到保护的作用,避免主体部21与二尖瓣瓣环1发生摩擦而对二尖瓣瓣环1造成损伤。Please refer to FIG. 5 and FIG. 6 , in some embodiments, the spacer 20 further includes a covering film 24 , the covering film 24 is elastic, and the covering film 24 covers the outside of the main body portion 21 and is fixedly connected with the main body portion 21 . It can be understood that due to the elasticity of the coating 24 , when the main body 21 is compressed in the axial direction and expands in the radial direction, the coating 24 covering the main body 21 can adapt to the deformed main body 21 . The covering film 24 plays a role of protection, preventing the main part 21 from rubbing against the mitral valve annulus 1 and causing damage to the mitral valve annulus 1 .
在图6的示例中,覆膜24可与呈网状结构的主体部21通过缝线缝合的方式固定连接在一起。可选地,覆膜24采用生物相容性良好的高分子材料制成,例如PET(Polyethylene Glycol Terephthalate,聚对苯二甲酸乙二醇酯)、PTFE(Poly tetra Fluoroethylene,聚四氟乙烯)等,本申请对此不作限定。当然,由多根支撑条212(如图11所示)围设而成的主体部21也可包覆有覆膜24。In the example shown in FIG. 6 , the covering film 24 can be fixedly connected with the main body portion 21 having a mesh structure by means of sutures. Optionally, the covering film 24 is made of a polymer material with good biocompatibility, such as PET (Polyethylene Glycol Terephthalate, polyethylene terephthalate), PTFE (Poly tetra Fluoroethylene, polytetrafluoroethylene), etc. , which is not limited in this application. Of course, the main body portion 21 surrounded by a plurality of support bars 212 (as shown in FIG. 11 ) can also be covered with a coating film 24 .
在图3的示例中,当收紧收紧线30时,间隔件20a被锚定组件10a与锚定组件10b挤压,其轴向上的相对两端面分别与锚定组件10a及锚定组件10b贴合,与此同时,其径向尺寸变大而与二尖瓣瓣环1贴合;间隔件20b被锚定组件10b与锚定组件10c挤压,其轴向上的相对两端面分别与锚定组件10b及锚定组件10c贴合,与此同时,其径向尺寸变大而与二尖瓣瓣环1贴合。这样,锚定组件10a、间隔件20a、锚定组件10b、间隔件20b、锚定组件10c以及二尖瓣瓣环1在位置关系上就连接在一起了。In the example of FIG. 3 , when the tightening wire 30 is tightened, the spacer 20a is squeezed by the anchoring component 10a and the anchoring component 10b, and its opposite ends in the axial direction are in contact with the anchoring component 10a and the anchoring component respectively. 10b, at the same time, its radial dimension becomes larger and fits with the mitral valve annulus 1; the spacer 20b is squeezed by the anchoring assembly 10b and the anchoring assembly 10c, and its opposite ends in the axial direction are respectively It fits with the anchoring component 10b and the anchoring component 10c, and at the same time, its radial dimension becomes larger and fits with the mitral valve annulus 1 . In this way, the anchoring assembly 10a, the spacer 20a, the anchoring assembly 10b, the spacer 20b, the anchoring assembly 10c and the mitral valve ring 1 are connected together in terms of positional relationship.
需要说明的是,当锚定组件10植入到二尖瓣瓣环1中时,收紧线30的牵引力要小于锚定组件10对二尖瓣瓣环1的锚定力,这样收紧收紧线30时,锚定组件10不会脱离二尖瓣瓣环1,保证植入物100能 稳定地对二尖瓣瓣环1进行缩环。除了收紧线30的牵引力外,二尖瓣瓣环1收缩的量还取决于二尖瓣瓣环1本身的组织硬度。可以理解,二尖瓣瓣环1的不同位置处的组织硬度不同,其中,前三角区和后三角区的硬度最硬。如图3所示,当锚定组件10a与锚定组件10b之间的瓣环组织较软时,锚定组件10b和锚定组件10c之间的瓣环组织较硬时,收紧收紧线30以缩小二尖瓣瓣环1,此时锚定组件10a与锚定组件10b之间的瓣环组织收缩量大于锚定组件10b和锚定组件10c之间的瓣环组织收缩量,换言之,锚定组件10a和锚定组件10b之间的间距小于锚定组件10b和锚定组件10c之间的间距。It should be noted that when the anchoring assembly 10 is implanted into the mitral valve annulus 1, the traction force of the tightening wire 30 should be smaller than the anchoring force of the anchoring assembly 10 on the mitral valve annulus 1, thus tightening When the wire 30 is tightened, the anchor assembly 10 will not break away from the mitral valve annulus 1, ensuring that the implant 100 can stably shrink the mitral valve annulus 1. In addition to the traction force of the tightening wire 30, the contraction amount of the mitral annulus 1 also depends on the tissue stiffness of the mitral annulus 1 itself. It can be understood that the tissue hardness at different positions of the mitral valve annulus 1 is different, among which, the hardness of the anterior trigone and the posterior trigone is the hardest. As shown in Figure 3, when the annulus tissue between the anchor assembly 10a and the anchor assembly 10b is soft, and when the annulus tissue between the anchor assembly 10b and the anchor assembly 10c is relatively hard, tighten the tightening wire 30 to shrink the mitral valve annulus 1, at this time, the shrinkage of the valve ring tissue between the anchoring assembly 10a and the anchoring assembly 10b is greater than the shrinkage of the valve ring tissue between the anchoring assembly 10b and the anchoring assembly 10c, in other words, The distance between the anchor component 10a and the anchor component 10b is smaller than the distance between the anchor component 10b and the anchor component 10c.
如图7及图8所示,锚定组件10a与锚定组件10b挤压间隔件20a,由于锚定组件10a与锚定组件10b之间的瓣环组织收缩量较大,间隔件20a被完全压缩(如图7所示的间隔件20),其主体部21不能再沿其轴向压缩,间隔件20a在其轴向上为刚性。如图9及图10所示,锚定组件10b与锚定组件10c挤压间隔件20b,由于锚定组件10b和锚定组件10c之间的瓣环组织收缩量较小,间隔件20b未被完全压缩(如图8所示的间隔件20),其主体部21还能沿其轴向继续压缩,间隔件20b在其轴向上仍具有弹性。可以理解,间隔件20a在其轴向上的中部位置的径向尺寸大于间隔件20b在其轴向上的中部位置的径向尺寸。As shown in Figures 7 and 8, the anchoring assembly 10a and the anchoring assembly 10b squeeze the spacer 20a, and the spacer 20a is completely compressed due to the large contraction of the annulus tissue between the anchoring assembly 10a and the anchoring assembly 10b. Compression (such as the spacer 20 shown in FIG. 7), its main body 21 can no longer be compressed along its axial direction, and the spacer 20a is rigid in its axial direction. As shown in Figures 9 and 10, the anchoring assembly 10b and the anchoring assembly 10c press the spacer 20b, and the spacer 20b is not compressed due to the small contraction of the annulus tissue between the anchoring assembly 10b and the anchoring assembly 10c. When fully compressed (as shown in the spacer 20 in FIG. 8 ), its main body 21 can continue to compress along its axial direction, and the spacer 20b still has elasticity in its axial direction. It can be understood that the radial dimension of the spacer 20 a at its axial middle position is larger than the radial dimension of the spacer 20 b at its axial middle position.
若此时二尖瓣反流仍较为严重,需继续收紧收紧线30进行缩环,每个锚定组件10受到收紧线30的牵拉力增大,继续压缩间隔件20a和间隔件20b。由于间隔件20a呈刚性无法继续压缩,锚定组件10a与锚定组件10b受到的牵拉力就会分散到其余的锚定组件10上,如锚定组件10c,从而锚定组件10b和锚定组件10c之间的间距将会继续被缩小,间隔件20b会被进一步压缩,直到对二尖瓣瓣环1的缩环达到理想效果,即二尖瓣反流减弱或者消失。If the mitral valve regurgitation is still serious at this time, it is necessary to continue to tighten the tightening wire 30 to shrink the ring, and each anchor assembly 10 is increased by the pulling force of the tightening wire 30, and the spacer 20a and the spacer are continuously compressed. 20b. Since the spacer 20a is rigid and cannot be further compressed, the pulling force received by the anchoring component 10a and the anchoring component 10b will be distributed to the remaining anchoring components 10, such as the anchoring component 10c, so that the anchoring component 10b and the anchoring component 10c The space between the components 10c will continue to be narrowed, and the spacer 20b will be further compressed until the ideal effect on the constriction of the mitral annulus 1 is achieved, that is, mitral valve regurgitation is weakened or disappeared.
当锚定组件10的数量超过三个,间隔件20的数量超过两个时,若间隔件20b被完全压缩而呈刚性时,对二尖瓣瓣环1的缩环仍未达到理想效果,可继续拉紧收紧线30,牵拉力继续增大,锚定组件10b和锚定组件10c受到的牵拉力就会部分传递到下一个锚定组件10上,以对下一个间隔件20进一步压缩,以此类推直至二尖瓣反流减弱或者消失。When the number of anchor assemblies 10 exceeds three and the number of spacers 20 exceeds two, if the spacers 20b are fully compressed and become rigid, the constriction of the mitral annulus 1 has not yet achieved the desired effect, and may Continue to tighten the tightening wire 30, the pulling force continues to increase, and the pulling force received by the anchor assembly 10b and the anchor assembly 10c will be partially transmitted to the next anchor assembly 10, so as to further strengthen the next spacer 20. Compression, and so on until the mitral valve regurgitation weakens or disappears.
因此,通过本实施方式的植入物100对二尖瓣瓣环1进行缩环时,每个锚定组件10受到收紧线30的牵拉力大致相同,但是由于锚定组件10植入在二尖瓣瓣环1的不同位置,且二尖瓣瓣环1本身各个位置的组织软硬不一,在瓣环组织硬度较软的地方,其收缩的量较大,相邻两个锚定组件10之间的间隔件20的轴向压缩量较多;在瓣环组织硬度较硬的地方,其收缩的量较小,相邻两个锚定组件10之间的间隔件20受到的挤压力较小,其轴向压缩量较少。相较瓣环组织较硬处的间隔件20,瓣环组织较软处的间隔件20更容易被完全压缩而呈刚性,其相邻的两个锚定组件10可将多余的牵拉力分散到其他锚定组件10,以便于其他间隔件20的进一步压缩变形,达到缩环的理想效果。由于间隔件20本身的轴向长度长且其可沿径向扩张,在植入在二尖瓣瓣环1的植入物100中,间隔件20与和其相邻的两个锚定组件10以及二尖瓣瓣环1均有较大的接触面积,尽可能消除了间隙,这有利于植入物100更好、更快地完成内皮化。Therefore, when the mitral valve annulus 1 is contracted by the implant 100 of this embodiment, each anchor assembly 10 receives approximately the same pulling force from the tightening wire 30, but since the anchor assembly 10 is implanted in Different locations of the mitral annulus 1, and the tissue at each location of the mitral annulus 1 itself varies in softness and hardness. In places where the hardness of the annulus tissue is softer, the amount of contraction is greater, and two adjacent anchors The axial compression amount of the spacer 20 between the components 10 is relatively large; where the annulus tissue hardness is relatively hard, the contraction amount is small, and the spacer 20 between two adjacent anchoring components 10 is squeezed. The pressure is less, and its axial compression is less. Compared with the spacer 20 at the harder part of the annulus, the spacer 20 at the softer part of the annulus is easier to be completely compressed and becomes rigid, and the two adjacent anchor components 10 can disperse the excess pulling force to other anchor components 10, so as to facilitate further compression deformation of other spacers 20, and achieve the ideal effect of shrinking rings. Since the axial length of the spacer 20 itself is long and it can expand radially, in the implant 100 implanted in the mitral valve annulus 1, the spacer 20 and the two adjacent anchor assemblies 10 And the mitral annulus 1 has a larger contact area, which eliminates the gap as much as possible, which is beneficial to the endothelialization of the implant 100 better and faster.
请一并参阅图2、图3以及图13,在一些实施方式中,锚定组件10包括锚钉11及设于锚钉11上的穿线结构12,收紧线30的远端与用于锚入心脏组织(即二尖瓣瓣环1)的第一个锚定组件(如图2中锚定组件10a)的穿线结构12连接,收紧线30的其他部分滑动穿过用于锚入心脏组织的其他锚定组件10的穿线结构12。Please refer to Fig. 2, Fig. 3 and Fig. 13 together. In some embodiments, the anchoring assembly 10 includes an anchor 11 and a threading structure 12 arranged on the anchor 11, and the distal end of the tightening wire 30 is used for anchoring. The threading structure 12 of the first anchoring assembly (such as the anchoring assembly 10a in Figure 2) that enters the heart tissue (i.e. the mitral valve annulus 1) is connected, and the other parts of the tightening wire 30 slide through for anchoring into the heart The threading structure 12 of the other anchoring assembly 10 of the tissue.
在图13的示例中,锚钉11包括钉座111及固定连接于钉座111远端的螺旋钉112。钉座111用于与外部器械连接,以便将锚定组件10输送至二尖瓣瓣环1(如图2所示)处。螺旋钉112用于锚入二尖瓣瓣环1等心脏组织。具体地,螺旋钉112的远端的尖端可刺入二尖瓣瓣环1,通过转动钉座111带动螺旋钉112转动而锚入二尖瓣瓣环1。虽然本文的锚钉11锚入心脏组织的部分以螺旋钉示例,但是在其他实施方式中,可以是具有使锚钉11能够与心脏组织接合并基本上固定到心脏组织的另一种合适的构造,例如但不限于倒钩,钩子,尖齿等。In the example shown in FIG. 13 , the anchor 11 includes a nail base 111 and a helical nail 112 fixedly connected to the distal end of the nail base 111 . The nail seat 111 is used for connecting with external instruments, so as to deliver the anchor assembly 10 to the mitral annulus 1 (as shown in FIG. 2 ). The helical nail 112 is used for anchoring into heart tissues such as the mitral annulus 1 . Specifically, the tip of the distal end of the helical nail 112 can penetrate into the mitral annulus 1 , and the helical nail 112 is driven to rotate by rotating the nail seat 111 to be anchored into the mitral annulus 1 . Although the part where the anchor 11 is anchored into the heart tissue is exemplified as a helical nail, in other embodiments, it may have another suitable configuration that enables the anchor 11 to engage with the heart tissue and be substantially fixed to the heart tissue. , such as but not limited to barbs, hooks, tines, etc.
收紧线30的远端可以通过包括但不限于打结、缠绕、焊接、粘接、卡接等方式,实现与用于锚入心脏组织的第一个锚定组件(如图2所示的锚定组件10a)的穿线结构12的连接。The distal end of the tightening wire 30 can realize the connection with the first anchoring component (as shown in FIG. Connection of the threading structure 12 of the anchor assembly 10a).
在一些实施方式中,穿线结构12包括穿线环121和连接件122,连接件122活动套设于锚钉11上,穿线环121活动连接连接件122,穿线环121用于连接收紧线30(如图2所示)。优选地,连接件122套设于钉座111上,可相对钉座111的中轴线转动。由于连接件122可相对钉座111的中轴线转动,当螺旋钉112随钉座111转动而锚入二尖瓣瓣环1(如图2所示)中时,可避免穿过穿线环121的收紧线30随钉座111转动而缠绕锚钉11,进而影响锚钉11锚入二尖瓣瓣环1中。同时由于连接件122可绕钉座111的中轴线转动,且穿线环121可相对连接件122活动,因此多个锚入二尖瓣瓣环1的锚定组件10分别通过穿线环121连接收紧线30后,当收紧线30收紧时锚定组件10的穿线环121可在收紧线30的牵拉力的作用下运动到配合收紧线30收紧后的状态,每一锚定组件10的穿线环121可运动使其穿线方向沿着二尖瓣瓣环1的周向,进而大大减小了收紧线30在收紧过程中的阻力,收紧线30不存在弯折的情况且收紧稳定顺畅,从而能够保证缩环的稳定性,缩环的效果良好。再者,由于收紧线30在收紧方向上所受阻力大大减小,牵拉力减小且牵拉力分布在每个锚定组件10上的作用力更加均匀,使得每个锚定组件10所受牵拉力大大减小,减小了每一锚定组件10对二尖瓣瓣环1的作用力,降低了二尖瓣瓣环1受到损伤的风险, 同时避免出现单个锚定组件10所受牵拉力占比较大的情况,降低了锚定组件10脱落的风险,植入更安全。In some embodiments, the threading structure 12 includes a threading ring 121 and a connecting piece 122, the connecting piece 122 is movably sleeved on the anchor 11, the threading ring 121 is movably connected to the connecting piece 122, and the threading ring 121 is used to connect the tightening wire 30 ( as shown in picture 2). Preferably, the connecting member 122 is sleeved on the nail base 111 and can rotate relative to the central axis of the nail base 111 . Because the connecting piece 122 can rotate relative to the central axis of the nail seat 111, when the screw 112 rotates with the nail seat 111 and is anchored in the mitral valve annulus 1 (as shown in FIG. The tightening wire 30 winds around the anchor 11 with the rotation of the nail seat 111 , thereby affecting the anchoring of the anchor 11 into the mitral annulus 1 . At the same time, because the connecting piece 122 can rotate around the central axis of the nail seat 111, and the threading ring 121 can move relative to the connecting piece 122, so a plurality of anchoring assemblies 10 anchored into the mitral annulus 1 are respectively connected and tightened through the threading ring 121 After the thread 30, when the tightening thread 30 is tightened, the threading ring 121 of the anchor assembly 10 can move to the state after the tightening thread 30 is tightened under the action of the pulling force of the tightening thread 30, each anchor The threading ring 121 of the assembly 10 can be moved so that the threading direction is along the circumferential direction of the mitral annulus 1, thereby greatly reducing the resistance of the tightening wire 30 during tightening, and the tightening wire 30 has no bending The situation and the tightening is stable and smooth, so that the stability of the shrinking ring can be guaranteed, and the effect of the shrinking ring is good. Furthermore, since the resistance of the tightening wire 30 in the tightening direction is greatly reduced, the pulling force is reduced and the force distributed by the pulling force on each anchor component 10 is more uniform, so that each anchor component The pulling force of 10 is greatly reduced, reducing the force of each anchoring component 10 on the mitral valve annulus 1, reducing the risk of damage to the mitral valve annulus 1, while avoiding the occurrence of a single anchoring component The fact that the pulling force on 10 is relatively large reduces the risk of the anchoring component 10 falling off, and the implantation is safer.
在其他实施方式中,穿线结构12可以是一个活动套设于锚钉11上的穿线环121。优选地,穿线环121活动套设于锚钉11的钉座111上;当然,穿线环121也可以活动套设于锚钉11的螺旋钉112上,保证穿线环121不从锚钉11上掉落即可。穿线结构12还可以是设于钉座111上的穿孔,穿孔的中轴线与钉座111的中轴线垂直,锚定组件10通过穿孔穿装于收紧线30上。In other embodiments, the threading structure 12 may be a threading ring 121 movably sleeved on the anchor 11 . Preferably, the threading ring 121 is movably sleeved on the nail seat 111 of the anchor 11; of course, the threading ring 121 can also be movably sleeved on the screw 112 of the anchor 11 to ensure that the threading ring 121 does not fall off from the anchor 11 just drop. The threading structure 12 can also be a perforation provided on the nail base 111 , the central axis of the perforation is perpendicular to the central axis of the nail base 111 , and the anchor assembly 10 is mounted on the tightening wire 30 through the perforation.
请一并参阅图3以及图14至图17,在一些实施方式中,植入物100还包括收线器40,收线器40包括壳体41及可转动地设于壳体41内的绕线轴42。收紧线30活动穿过壳体41及绕线轴42,绕线轴42相对于壳体41转动以卷绕收紧线30。绕线轴42停止转动时,收紧线30被锁紧于绕线轴42与壳体41之间的径向空间43内。Please refer to FIG. 3 and FIG. 14 to FIG. 17 together. In some embodiments, the implant 100 further includes a wire retractor 40, and the wire retractor 40 includes a housing 41 and a coil rotatably arranged in the housing 41. Spool 42. The tightening wire 30 moves through the housing 41 and the winding shaft 42 , and the winding shaft 42 rotates relative to the housing 41 to wind the tightening wire 30 . When the winding shaft 42 stops rotating, the tightening wire 30 is locked in the radial space 43 between the winding shaft 42 and the casing 41 .
由此,当多个锚定组件10依次植入二尖瓣瓣环1后,多个锚定组件10及多个间隔件20交替穿装于收紧线30上,此时可将收紧线30穿过壳体41及绕线轴42,使收线器40活动穿装于收紧线30上,收线器40沿收紧线30输送至二尖瓣瓣环1处,与最后一个锚定组件10或最后一个间隔件20接触。通过控制绕线轴42相对壳体41转动可卷绕收紧线30,使得收紧线30不断收紧而对二尖瓣瓣环1进行缩环,直至二尖瓣反流减弱或者消失即可停止转动绕线轴42,此时收紧线30被锁紧于绕线轴42与壳体41之间的径向空间43内,收紧线30在二尖瓣瓣环1上保持一定的长度。可以理解,通过收线器40卷绕锁定收紧线30对二尖瓣瓣环1的进行缩环,收紧线30的锁紧效果好。而且,若经过一段时间,患者的二尖瓣瓣环1又出现扩大导致反流复发,可直接控制收线器40进一步卷绕收紧线30缩小瓣环以使反流减弱或者消失,避免二次手术对患者造成较大的伤害。收线器40可采用316L不锈钢制成,或者其他具有生物相容性的材料制成,本申请对此不作限定。Thus, when a plurality of anchoring assemblies 10 are sequentially implanted into the mitral valve annulus 1, a plurality of anchoring assemblies 10 and a plurality of spacers 20 are alternately worn on the tightening wire 30, at this time the tightening wire can be 30 passes through the casing 41 and the winding shaft 42, so that the wire take-up device 40 can be movably worn on the tightening wire 30, and the wire take-up device 40 is transported to the mitral annulus 1 along the tightening wire 30, and is anchored with the last one The assembly 10 or the last spacer 20 is in contact. By controlling the winding shaft 42 to rotate relative to the casing 41, the tightening wire 30 can be wound, so that the tightening wire 30 is continuously tightened to shrink the mitral valve annulus 1 until the mitral valve regurgitation weakens or disappears. Rotate the bobbin 42, at this time the tightening wire 30 is locked in the radial space 43 between the bobbin 42 and the housing 41, and the tightening wire 30 maintains a certain length on the mitral annulus 1. It can be understood that the locking effect of the tightening wire 30 is good when the mitral annulus 1 is retracted by winding and locking the tightening wire 30 with the wire retractor 40 . Moreover, if after a period of time, the patient's mitral valve annulus 1 expands again and causes regurgitation to recur, the wire take-up device 40 can be directly controlled to further coil the tightening wire 30 to reduce the valve annulus so that the regurgitation weakens or disappears, avoiding two The operation caused great harm to the patient. The wire take-up 40 can be made of 316L stainless steel, or other biocompatible materials, which is not limited in this application.
需要说明的是,收紧线30在绕线轴42上至少卷绕三圈,收紧线30与绕线轴42之间的摩擦力可抵消二尖瓣瓣叶活动产生的拉力,保证收紧线30不被瓣叶活动产生的拉力拉动。It should be noted that the tightening wire 30 is wound at least three times on the winding shaft 42, and the frictional force between the tightening wire 30 and the winding shaft 42 can offset the pulling force generated by the movement of the mitral valve leaflets, ensuring that the tightening wire 30 Not pulled by the pulling force created by leaflet activity.
请参阅图16和图17,收线器40还包括限位柱44、止转轮45和弹性件46。壳体41包括底壳411和外壳412,外壳412的近端及远端均开口,底壳411固定连接于外壳412的远端,形成安装空间413。安装空间413用于收容绕线轴42、限位柱44、止转轮45及弹性件46。绕线轴42沿其径向设有通孔421,外壳412在绕线轴42的两侧设有两个线孔4121,两个线孔4121均连通绕线轴42的通孔421。将收线器40穿装于收紧线30上时,收紧线30先自一个线孔4121穿入壳体41的安装空间413中,然后穿过绕线轴42的通孔421,再从另一个线孔4121穿出壳体41。优选地,两个线孔4121的中轴线与通孔421的中轴线处于同一平面,可转动绕线轴42使通孔421的中轴线与两个线孔4121的中轴线共线,这样有利于收紧线30顺畅地穿过两个线孔4121及通孔421。限位柱44的远端与底壳411固定连接,止转轮45套设于限位柱44上,可沿限位柱44轴向移动。止转轮45的近端面沿周向环设若干第一斜齿451,绕线轴42的远端面沿周向环设若干第二斜齿422,绕线轴42套设于限位柱44上,使第二斜齿422可与第一斜齿451配合单向转动。弹性件46位于止转轮45与底壳411之间,一端抵持底壳411,一端抵持止转轮45,弹性件46用于向止转轮45提供弹力,使得止转轮45的第一斜齿451贴合绕线轴42的第二斜齿422。当绕线轴42正转时,第二斜齿422在第一斜齿451上打滑使止转轮45向远端移动,当绕线轴42相对止转轮45转过一个斜齿的角度后,止转轮45受到弹性件46给予的弹力后会向近端移动,使得第一斜齿451和第二斜齿422重新贴合,绕线轴42可继续相对止动轮45转动。当要反向转动绕线轴42时,第二斜齿422无法使止转轮45向远端移动,第二斜齿422无法越过任何一个第一斜齿451导致绕线轴42无法反转。因此,当绕线轴42停止转动时,收紧线30能被锁紧于绕线轴42与壳体41之间的径向空间43内。需要说明的是,图示实施方式中,径向空间43指的是绕线轴42与外壳412合围形成的空间,径向空间43为安装空间413的一部分。Please refer to FIG. 16 and FIG. 17 , the wire take-up 40 also includes a limiting post 44 , a rotation stop wheel 45 and an elastic member 46 . The housing 41 includes a bottom shell 411 and an outer shell 412 , the proximal end and the distal end of the shell 412 are open, and the bottom shell 411 is fixedly connected to the distal end of the shell 412 to form an installation space 413 . The installation space 413 is used for accommodating the winding shaft 42 , the limiting post 44 , the anti-rotation wheel 45 and the elastic member 46 . The winding shaft 42 is provided with a through hole 421 along its radial direction, and the shell 412 is provided with two wire holes 4121 on both sides of the winding shaft 42 , and the two wire holes 4121 are connected to the through hole 421 of the winding shaft 42 . When threading the wire take-up device 40 on the tightening wire 30, the tightening wire 30 first passes through a wire hole 4121 into the installation space 413 of the housing 41, then passes through the through hole 421 of the bobbin 42, and then passes through another wire hole 4121. A wire hole 4121 passes through the casing 41 . Preferably, the central axis of the two wire holes 4121 is in the same plane as the central axis of the through hole 421, and the rotatable bobbin 42 makes the central axis of the through hole 421 collinear with the central axis of the two wire holes 4121, which is conducive to the collection The tight wire 30 passes through the two wire holes 4121 and the through hole 421 smoothly. The distal end of the limiting post 44 is fixedly connected to the bottom case 411 , and the anti-rotation wheel 45 is sheathed on the limiting post 44 and can move axially along the limiting post 44 . The near-end surface of the anti-rotation wheel 45 is provided with some first helical teeth 451 along the circumferential ring, and the far-end surface of the winding shaft 42 is provided with some second helical teeth 422 along the circumferential ring, and the winding shaft 42 is sleeved on the limit post 44, so that the second The helical tooth 422 can cooperate with the first helical tooth 451 to rotate in one direction. The elastic member 46 is located between the anti-rotation wheel 45 and the bottom shell 411, one end is against the bottom case 411, and the other end is against the anti-rotation wheel 45. A helical tooth 451 engages with the second helical tooth 422 of the winding shaft 42 . When the bobbin 42 rotated forward, the second helical tooth 422 slipped on the first helical tooth 451 to make the anti-rotation wheel 45 move to the far end. The rotating wheel 45 will move proximally after receiving the elastic force given by the elastic member 46 , so that the first helical teeth 451 and the second helical teeth 422 are reattached, and the bobbin 42 can continue to rotate relative to the stop wheel 45 . When the bobbin 42 is to be rotated in the reverse direction, the second helical tooth 422 cannot move the anti-rotation wheel 45 to the distal end, and the second helical tooth 422 cannot pass over any one of the first helical teeth 451 so that the bobbin 42 cannot reverse. Therefore, when the winding shaft 42 stops rotating, the take-up wire 30 can be locked in the radial space 43 between the winding shaft 42 and the casing 41 . It should be noted that, in the illustrated embodiment, the radial space 43 refers to the space formed by the winding shaft 42 and the casing 412 , and the radial space 43 is a part of the installation space 413 .
绕线轴42远端面还设有一与限位柱44的近端配合的凹槽423,限位柱44的近端面与绕线轴42的远端面接触,与外壳412的近端共同限制绕线轴42在安装空间413中的轴向位移,使得绕线轴42只能转动。止转轮45近端还设有限位凸台452,外壳412远端设有限位槽,限位凸台452卡设于限位槽中,可以限制止转轮45发生转动,使止转轮45只能沿限位柱44的轴向移动。The far end surface of the bobbin 42 is also provided with a groove 423 that cooperates with the proximal end of the limit post 44. The proximal surface of the limit post 44 contacts the far end surface of the bobbin 42, and the proximal end of the housing 412 jointly limits the winding. The axial displacement of the bobbin 42 in the installation space 413 makes the bobbin 42 only rotatable. The near-end of the anti-rotation wheel 45 is also provided with a limiting boss 452, and the far-end of the shell 412 is provided with a limiting groove, and the limiting boss 452 is stuck in the limiting groove, which can limit the rotation of the anti-rotating wheel 45, so that the anti-rotating wheel 45 It can only move along the axial direction of the limit post 44 .
在其他实施方式中,如图2所示,在二尖瓣瓣环1植入多个锚定组件10及间隔件20后,牵拉收紧线30进行缩环,使二尖瓣反流减弱或消失后,可沿收紧线30送入锁钉(图中未示)对收紧后的收紧线30进行锁结,使收紧线30保持收紧后的状态,收紧线30多余的部分可裁剪取出。In other embodiments, as shown in FIG. 2 , after the mitral annulus 1 is implanted with a plurality of anchor assemblies 10 and spacers 20, the tightening wire 30 is pulled to shrink the annulus to weaken mitral valve regurgitation. Or after disappearing, can send into lock nail (not shown in the figure) along the tightening line 30 and lock the tightening line 30 after tightening, make the tightening line 30 keep the state after tightening, the tightening line 30 is superfluous The part can be cut out.
请一并参阅图2、图3以及图18至图21,本申请实施方式还提供了一种经导管心脏修复系统1000,其包括输送装置200、锚定装置300及上述植入物100。输送装置200包括输送鞘管201,锚定装置300活动穿装于输送鞘管201的内腔2011中,锚定组件10穿装于输送鞘管201的远端内腔中,锚定组件10与锚定装置300的远端可拆卸连接。输送鞘管201用于将锚定组件10输送至心脏组织(即二尖瓣瓣环1)处,锚定装置300用于驱动锚定组件10锚入心脏组织。Please refer to FIG. 2 , FIG. 3 , and FIG. 18 to FIG. 21 . The embodiment of the present application also provides a transcatheter cardiac repair system 1000 , which includes a delivery device 200 , an anchoring device 300 and the aforementioned implant 100 . The delivery device 200 includes a delivery sheath 201, the anchoring device 300 is movably worn in the lumen 2011 of the delivery sheath 201, the anchor assembly 10 is worn in the distal end lumen of the delivery sheath 201, and the anchor assembly 10 and The distal end of the anchoring device 300 is detachably connected. The delivery sheath 201 is used to deliver the anchor assembly 10 to the heart tissue (ie, the mitral annulus 1 ), and the anchor device 300 is used to drive the anchor assembly 10 to anchor into the heart tissue.
可以理解,在将锚定组件10输送二尖瓣瓣环1处时,需先将锚定装置300及锚定组件10穿装于输送鞘管201的内腔2011中。具体地,可先将锚定装置300的远端沿输送鞘管201的内腔2011自输送鞘管201 的远端穿出,然后将锚定组件10与锚定装置300连接,朝近端后撤锚定装置300,直至锚定组件10穿装于输送鞘管201的远端内腔中。之后推送输送鞘管201将锚定装置300及锚定组件10输送至二尖瓣瓣环1处,通过锚定装置300驱动锚定组件10锚入二尖瓣瓣环1。需要说明的是,输送鞘管201的内腔2011沿输送鞘管201的轴向贯穿其相对两端面,远端内腔指的是内腔2011位于输送鞘管201远端的空间。It can be understood that when the anchoring assembly 10 is delivered to the mitral annulus 1 , the anchoring device 300 and the anchoring assembly 10 need to be inserted into the lumen 2011 of the delivery sheath 201 first. Specifically, firstly, the distal end of the anchoring device 300 can be passed through the distal end of the delivery sheath 201 along the lumen 2011 of the delivery sheath 201, and then the anchor assembly 10 is connected with the anchoring device 300, and the The anchoring device 300 is withdrawn until the anchoring assembly 10 is worn in the distal lumen of the delivery sheath 201 . Afterwards, the delivery sheath 201 is pushed to deliver the anchoring device 300 and the anchoring assembly 10 to the annulus 1 of the mitral valve, and the anchoring device 300 drives the anchoring assembly 10 to be anchored into the annulus 1 of the mitral valve. It should be noted that the lumen 2011 of the delivery sheath 201 runs through the two opposite ends of the delivery sheath 201 along the axial direction, and the distal lumen refers to the space where the lumen 2011 is located at the distal end of the delivery sheath 201 .
请参阅图19至图21,在一些实施方式中,锚定装置300包括驱动管301及穿装于驱动管301中的连接杆302,锚定组件10的近端设有第一连接部113,驱动管301的远端设有与第一连接部113可拆卸连接的第二连接部303,连接杆302沿驱动管301的轴向穿设于配合连接的第一连接部1013及第二连接部303中以保持驱动管301与锚定组件10之间的连接,驱动管301用于驱动锚定组件10锚入心脏组织(即如图3所示的二尖瓣瓣环1)。这样,通过穿设于第一连接部113及第二连接部303中的连接杆302可保持驱动管301与锚定组件10之间的连接,朝近端后撤连接杆302,就可解除驱动管301与锚定组件10之间的连接,操作简单,便于拆装。Referring to FIGS. 19 to 21 , in some embodiments, the anchoring device 300 includes a driving tube 301 and a connecting rod 302 mounted in the driving tube 301 , and the proximal end of the anchoring component 10 is provided with a first connecting portion 113 , The distal end of the driving tube 301 is provided with a second connecting part 303 that is detachably connected to the first connecting part 113, and the connecting rod 302 is passed through the first connecting part 1013 and the second connecting part that are mated and connected along the axial direction of the driving tube 301. 303 to maintain the connection between the driving tube 301 and the anchoring assembly 10, and the driving tube 301 is used to drive the anchoring assembly 10 to anchor into the heart tissue (ie, the mitral annulus 1 as shown in FIG. 3 ). In this way, the connection between the driving tube 301 and the anchor assembly 10 can be maintained by the connecting rod 302 passing through the first connecting part 113 and the second connecting part 303, and the driving can be released by withdrawing the connecting rod 302 towards the proximal end. The connection between the pipe 301 and the anchor assembly 10 is easy to operate and easy to assemble and disassemble.
具体地,第一连接部113为凸设于锚钉11的钉座111近端的S型卡扣,第二连接部303为凸设于驱动管301远端的S型卡扣,两个S型卡扣可对应扣合。当第一连接部113与第二连接部303对应扣合后,连接杆302沿驱动管301的轴向穿过第一连接部113及第二连接部303与钉座111抵压,通过连接杆302就可保持第一连接部113与第二连接部303之间的扣合,从而锚定组件10与锚定装置300保持连接。此时,通过转动驱动管301就可带动锚钉11转动而锚入二尖瓣瓣环1(如图3所示),即锚定组件10锚入二尖瓣瓣环1。然后,朝近端后撤连接杆302,直至连接杆302不再穿过第一连接部113与第二连接部303的连接位置,此时,后撤驱动管301即可解除锚定装置300与锚定组件10的连接。在本实施方式中,驱动管301及连接杆302均采用不锈钢304V制成,当然也可以由其他材质制成,本申请对此不作限定。Specifically, the first connecting part 113 is an S-shaped buckle protruding from the proximal end of the nail seat 111 of the anchor 11, the second connecting part 303 is an S-shaped buckle protruding from the distal end of the driving tube 301, and the two S Type buckles can be buckled correspondingly. When the first connecting part 113 and the second connecting part 303 are correspondingly engaged, the connecting rod 302 passes through the first connecting part 113 and the second connecting part 303 along the axial direction of the drive tube 301 and presses against the nail base 111. 302 can keep the fastening between the first connecting part 113 and the second connecting part 303 , so that the anchoring assembly 10 and the anchoring device 300 are kept connected. At this time, by rotating the driving tube 301 , the anchor 11 can be driven to rotate and be anchored into the mitral annulus 1 (as shown in FIG. 3 ), that is, the anchor assembly 10 is anchored into the mitral annulus 1 . Then, withdraw the connecting rod 302 toward the proximal end until the connecting rod 302 no longer passes through the connection position between the first connecting part 113 and the second connecting part 303. Anchor assembly 10 connection. In this embodiment, both the driving tube 301 and the connecting rod 302 are made of stainless steel 304V, of course, they can also be made of other materials, which is not limited in this application.
请参阅图22,在一些实施方式中,输送鞘管201的管壁设有连通其内腔2011的通槽2012,通槽2012呈一字型并沿输送鞘管201的轴向延伸至输送鞘管201的远端端部,即通槽2012在输送鞘管201的远端端部具有开口。当锚定装置300自输送鞘管201的远端穿出而与锚定组件10连接后,朝近端后撤锚定装置300,锚定组件10的穿线环121随锚定装置300的后撤穿入通槽2012中,并沿通槽2012朝近端移动,直至锚定组件10随锚定装置300穿装于输送鞘管201的内腔2011中。Please refer to FIG. 22 , in some embodiments, the wall of the delivery sheath 201 is provided with a through groove 2012 communicating with its lumen 2011 , the through groove 2012 is in the shape of a straight line and extends to the delivery sheath along the axial direction of the delivery sheath 201 The distal end of the tube 201 , the channel 2012 has an opening at the distal end of the delivery sheath 201 . After the anchoring device 300 passes through the distal end of the delivery sheath 201 and is connected with the anchoring assembly 10, the anchoring device 300 is retracted toward the proximal end, and the threading ring 121 of the anchoring assembly 10 is withdrawn with the withdrawal of the anchoring device 300. penetrate into the through groove 2012 , and move toward the proximal end along the through groove 2012 until the anchor assembly 10 is inserted into the lumen 2011 of the delivery sheath 201 along with the anchor device 300 .
可以理解,穿线环121自通槽2012露于输送鞘管201的外部,这样的设计,便于收紧线30穿过,便于将锚定组件10穿装于收紧线30上;而且,由于收紧线30位于输送鞘管201的外部,在锚定组件10锚入二尖瓣瓣环1(如图3所示)的过程中,这可防止收紧线30缠绕锚钉11,避免影响锚定组件10的锚入。优选地,通槽2012的开口处设有倒角或倒圆角,这有利于锚定组件10穿入通槽2012中,便于装配,有利于提高手术效率。It can be understood that the threading ring 121 is exposed to the outside of the delivery sheath 201 from the through groove 2012. Such a design facilitates the passage of the tightening wire 30 and facilitates the anchoring assembly 10 to be worn on the tightening wire 30; The tightening wire 30 is located outside the delivery sheath 201, during the process of anchoring the anchor assembly 10 into the mitral annulus 1 (as shown in FIG. 3 ), this can prevent the tightening wire 30 from wrapping around the anchor 11 and avoid affecting the anchor. Anchoring of the fixed assembly 10. Preferably, the opening of the through groove 2012 is provided with chamfers or rounded corners, which facilitates the insertion of the anchor assembly 10 into the through groove 2012, facilitates assembly, and improves operation efficiency.
进一步地,输送鞘管201的远端还设有止挡件2013,止挡件2013用于关闭或打开通槽2012在输送鞘管201的远端端部的开口。在穿装锚定组件10时,操作止挡件2013打开通槽2012的开口,使得锚定组件10的穿线环121可自开口进入通槽2012中。当锚定组件10穿装于输送鞘管201的内腔2011中后,操作止挡件2013关闭通槽2012的开口,避免位于输送鞘管201外部的收紧线30自通槽2012掉入输送鞘管201的内腔2011中而与锚钉11(如图21所示)发生缠绕。同时,锚定组件10的穿线环121无法自通槽2012的开口滑出,也能防止锚定组件10在输送过程中脱离输送鞘管201。Further, the distal end of the delivery sheath 201 is further provided with a stopper 2013 , and the stopper 2013 is used to close or open the opening of the channel 2012 at the distal end of the delivery sheath 201 . When the anchor assembly 10 is worn, the stopper 2013 is operated to open the opening of the through groove 2012 , so that the threading ring 121 of the anchor assembly 10 can enter the through groove 2012 from the opening. After the anchor assembly 10 is installed in the lumen 2011 of the delivery sheath 201, the stopper 2013 is operated to close the opening of the channel 2012, preventing the tightening wire 30 outside the delivery sheath 201 from falling into the delivery channel 2012. The inner cavity 2011 of the sheath tube 201 is entangled with the anchor 11 (as shown in FIG. 21 ). At the same time, the threading ring 121 of the anchoring assembly 10 cannot slide out from the opening of the through groove 2012 , which also prevents the anchoring assembly 10 from detaching from the delivery sheath 201 during delivery.
请参阅图18,在一些实施方式中,输送装置200还包括输送线202,输送线202的远端与收紧线30的近端连接。这样,可以采用长度足够长的输送线202,对应地,可采用长度较短的收紧线30,在收紧线30被锁紧后,无需裁剪收紧线30。输送线202与收紧线30连接,当与收紧线30的远端连接的第一个锚定组件10输送至二尖瓣瓣环1处后,输送线202可延伸至人体体外。后续植入的锚定组件10、间隔件20、收线器40可自体外通过输送线202滑动穿装于收紧线30上。当植入物100植入并留存在二尖瓣瓣环1处后,输送线202可解除与收紧线30的连接,输送线202可自人体内取出。Referring to FIG. 18 , in some embodiments, the delivery device 200 further includes a delivery wire 202 , the distal end of the delivery wire 202 is connected to the proximal end of the tightening wire 30 . In this way, a sufficiently long conveying line 202 can be used, and correspondingly, a shorter tightening line 30 can be used. After the tightening line 30 is locked, there is no need to cut the tightening line 30 . The delivery wire 202 is connected to the tightening wire 30 , and after the first anchoring assembly 10 connected to the distal end of the tightening wire 30 is delivered to the mitral annulus 1 , the delivery wire 202 can be extended outside the human body. The anchor assembly 10 , the spacer 20 , and the wire retractor 40 to be implanted later can be slid on the tightening wire 30 through the delivery wire 202 outside the body. After the implant 100 is implanted and left at the mitral annulus 1, the delivery wire 202 can be disconnected from the tightening wire 30, and the delivery wire 202 can be taken out from the human body.
需要说明的是,收紧线30具有一定轴向长度且具有柔性,收紧线30的径向截面形状可以是圆形、扁圆形、矩形、方形或其他形状等;同样,输送线202也具有一定轴向长度且具有柔性,输送线202的径向截面形状也可以是圆形、扁圆形、矩形、方形或其他形状等;本申请对收紧线30及输送线202的径向截面形状不作具体的限定。当输送装置200省去输送线202时,收紧线30的长度足够长可延伸至患者体外。收紧线30收紧完成缩环后,无论收紧线30是通过收线器40锁定保持收紧的状态还是通过锁钉(图中未示)锁定保持收紧的状态,均需对多余的收紧线30进行裁剪取出。It should be noted that the tightening wire 30 has a certain axial length and is flexible, and the radial cross-sectional shape of the tightening wire 30 can be circular, oblate, rectangular, square or other shapes; With a certain axial length and flexibility, the radial cross-sectional shape of the conveying line 202 can also be circular, oblate, rectangular, square or other shapes; The shape is not specifically limited. When the delivery device 200 omits the delivery wire 202, the length of the cinch wire 30 is long enough to extend outside the patient's body. After the tightening line 30 is tightened and the shrinking ring is completed, no matter whether the tightening line 30 is locked and kept tightened by the wire take-up device 40 or locked and kept tightened by a locking nail (not shown in the figure), redundant Tighten the thread 30 for cutting and taking out.
请参阅图18,在一些实施方式中,经导管心脏修复系统1000还包括导引鞘管500。导引鞘管500用于建立从患者体外到二尖瓣瓣环1(如图23所示)的介入通道,输送鞘管201可通过导引鞘管500输送锚定组件10及间隔件20(如图26所示)至二尖瓣瓣环1处。在图18的示例中,经导管心脏修复系统1000包括两个导引鞘管500,分别为第一导引鞘管501及穿装于第一导引鞘管501中的第二导引鞘管502,第二导引鞘管502可自第一导引鞘管501的远端伸出并贴合在二尖瓣瓣环1上,进而建立从人体体外到二尖瓣瓣环1的介入通道。优选地,第一导引鞘管501及第二导引鞘管502均为可调弯鞘管,这样更好调节导引鞘管500远端的弯曲角度及方向,进而有利于将导引鞘管500的远端调整至贴合二尖瓣瓣环1的角度。 当然,在其他实施方式中,也可以只采用一个可调弯的导引鞘管500。可调弯的鞘管为现有技术中介入手术常用的导引装置,在此不作赘述。Referring to FIG. 18 , in some embodiments, the transcatheter cardiac repair system 1000 further includes an introducing sheath 500 . The guide sheath 500 is used to establish an intervention channel from the outside of the patient's body to the mitral valve annulus 1 (as shown in FIG. As shown in Figure 26) to the mitral annulus 1. In the example of FIG. 18 , the transcatheter cardiac repair system 1000 includes two guiding sheaths 500 , which are respectively a first guiding sheath 501 and a second guiding sheath worn in the first guiding sheath 501 502, the second guide sheath 502 can protrude from the distal end of the first guide sheath 501 and fit on the mitral valve annulus 1, thereby establishing an intervention channel from the outside of the human body to the mitral valve annulus 1 . Preferably, both the first guiding sheath 501 and the second guiding sheath 502 are adjustable curved sheaths, so that the bending angle and direction of the distal end of the guiding sheath 500 can be better adjusted, which in turn facilitates the introduction of the guiding sheath. The distal end of the tube 500 is adjusted to fit the angle of the mitral annulus 1 . Certainly, in other embodiments, only one adjustable bendable guiding sheath 500 may also be used. The adjustable sheath tube is a commonly used guide device in interventional surgery in the prior art, and will not be described in detail here.
请参阅图18和图26,在一些实施方式中,经导管心脏修复系统1000还包括推送杆600,推送杆600的远端设有导引孔601,间隔件20穿装于输送线202上后,输送线202活动穿过导引孔601,推送杆600沿输送线202推送间隔件20进入导引鞘管500中,输送鞘管201活动穿装于导引鞘管500中以在导引鞘管500中推送间隔件20,以使间隔件20沿输送线202穿装于收紧线30上。Please refer to FIG. 18 and FIG. 26 , in some embodiments, the transcatheter cardiac repair system 1000 further includes a push rod 600 , the distal end of the push rod 600 is provided with a guide hole 601 , and after the spacer 20 is worn on the delivery wire 202 , the delivery line 202 moves through the guide hole 601, the push rod 600 pushes the spacer 20 along the delivery line 202 and enters the guide sheath 500, and the delivery sheath 201 is movably worn in the guide sheath 500 so that the guide sheath The spacer 20 is pushed in the tube 500 so that the spacer 20 is threaded on the take-up line 30 along the delivery line 202 .
可以理解,如图26及图27所示,在二尖瓣瓣环1(如图3所示)植入第一个锚定组件10后,撤出输送鞘管201及锚定装置300,间隔件20可自体外穿装于输送线202上,输送线202的近端穿过推送杆600的导引孔601,推送杆600可将间隔件20沿输送线202推送至导引鞘管500中。然后,取出推送杆600,将装于输送鞘管201中的第二个锚定组件10通过其露于输送鞘管201外部的穿线环121穿装于输送线202上,输送鞘管201进一步穿装于导引鞘管500中,间隔件20位于输送鞘管201的远端一侧。由此,输送鞘管201在导引鞘管500中沿轴向向远端移动,即可沿输送线202将间隔件20及锚定组件10穿装于收紧线30上,并将间隔件20推送至二尖瓣瓣环1处,然后锚定装置300将第二个锚定组件10推出输送鞘管201并将第二个锚定组件10锚入二尖瓣瓣环1,使得间隔件20位于两个锚定组件10之间。重复同样的步骤,依次将多个锚定组件10植入二尖瓣瓣环1,同时多个间隔件20依次穿插在每两个锚定组件10之间。It can be understood that, as shown in FIG. 26 and FIG. 27, after the first anchoring assembly 10 is implanted in the mitral valve annulus 1 (as shown in FIG. 3 ), the delivery sheath 201 and the anchoring device 300 are withdrawn. The part 20 can be worn outside the body on the delivery line 202, the proximal end of the delivery line 202 passes through the guide hole 601 of the push rod 600, and the push rod 600 can push the spacer 20 into the guide sheath 500 along the delivery line 202 . Then, the push rod 600 is taken out, and the second anchor assembly 10 installed in the delivery sheath tube 201 is threaded on the delivery line 202 through the threading ring 121 exposed outside the delivery sheath tube 201, and the delivery sheath tube 201 is further threaded. Installed in the introducing sheath 500 , the spacer 20 is located on the distal side of the delivery sheath 201 . Thus, the delivery sheath 201 moves axially and distally in the guide sheath 500, so that the spacer 20 and the anchor assembly 10 can be threaded on the tightening wire 30 along the delivery line 202, and the spacer 20 is pushed to the mitral annulus 1, and then the anchoring device 300 pushes the second anchor assembly 10 out of the delivery sheath 201 and anchors the second anchor assembly 10 into the mitral annulus 1, so that the spacer 20 is located between the two anchor assemblies 10 . The same steps are repeated, and multiple anchor assemblies 10 are implanted into the mitral valve annulus 1 sequentially, while multiple spacers 20 are sequentially inserted between every two anchor assemblies 10 .
请参阅图17和图18,在一些实施方式中,经导管心脏修复系统1000还包括调节工具400,收线器40可拆卸连接于调节工具400的远端,调节工具400用于驱动收线器40将收紧线30(如图15所示)收紧。Please refer to FIG. 17 and FIG. 18 , in some embodiments, the transcatheter heart repair system 1000 further includes an adjustment tool 400, the wire retractor 40 is detachably connected to the distal end of the adjustment tool 400, and the adjustment tool 400 is used to drive the wire retractor 40 tightens up the tightening line 30 (as shown in Figure 15).
具体地,调节工具400包括由外至内依次套设的外鞘管401、旋转管402以及螺纹杆403。外鞘管401与收线器40的壳体41连接以限制壳体41转动,旋转管402与绕线轴42的近端卡接,螺纹杆403与绕线轴42螺接而抵压旋转管402使旋转管402与绕线轴42保持连接。因此,通过转动旋转管402就可带动绕线轴42转动以卷绕收紧线30将收紧线30收紧。Specifically, the adjustment tool 400 includes an outer sheath tube 401 , a rotating tube 402 and a threaded rod 403 that are sheathed sequentially from outside to inside. The outer sheath tube 401 is connected with the housing 41 of the wire take-up 40 to limit the rotation of the housing 41, the rotating tube 402 is clamped with the proximal end of the winding shaft 42, and the threaded rod 403 is screwed with the winding shaft 42 to press the rotating tube 402 so that The rotating tube 402 remains connected to the bobbin 42 . Therefore, the winding shaft 42 can be driven to rotate by rotating the rotating tube 402 to wind the tightening wire 30 to tighten the tightening wire 30 .
在一些实施方式中,壳体41的外壳412设有卡槽4122,外鞘管401的远端设有与卡槽4122对应的卡爪4011,通过卡爪4011与卡槽4122的配合,外鞘管401与壳体41实现连接。绕线轴42的近端自外壳412的近端开口伸出,绕线轴42的近端沿其轴向设有螺纹孔424。旋转管402的内壁凸设有第一凸台4021,螺纹杆403的外壁凸设有第二凸台4031。旋转管402与绕线轴42卡接后,螺纹杆403与螺纹孔424螺接,即螺纹杆403与绕线轴42螺接,使第一凸台4021抵压于绕线轴42与第二凸台4031之间,旋转管402与绕线轴42保持连接。此时,外鞘管401限制壳体41转动,转动旋转管402就可带动螺纹杆403及绕线轴42同步转动,从而绕线轴42相对壳体41转动而卷绕收紧线30(如图15所示)而将收紧线30收紧。In some embodiments, the shell 412 of the housing 41 is provided with a slot 4122, and the distal end of the outer sheath tube 401 is provided with a claw 4011 corresponding to the slot 4122. Through the cooperation between the claw 4011 and the slot 4122, the outer sheath The pipe 401 is connected with the casing 41 . The proximal end of the bobbin 42 protrudes from the proximal opening of the housing 412 , and the proximal end of the bobbin 42 is provided with a threaded hole 424 along its axial direction. A first boss 4021 protrudes from the inner wall of the rotating tube 402 , and a second boss 4031 protrudes from the outer wall of the threaded rod 403 . After the rotating tube 402 is clamped with the winding shaft 42, the threaded rod 403 is screwed with the threaded hole 424, that is, the threaded rod 403 is screwed with the winding shaft 42, so that the first boss 4021 presses against the winding shaft 42 and the second boss 4031 Between, the rotating tube 402 is kept connected with the winding shaft 42 . At this time, the outer sheath tube 401 restricts the rotation of the housing 41, and the rotation of the rotating tube 402 can drive the threaded rod 403 and the bobbin 42 to rotate synchronously, so that the bobbin 42 rotates relative to the casing 41 to wind the tightening wire 30 (as shown in Figure 15 shown) and the tightening line 30 is tightened.
请一并参阅图18以及图23至图28,以下以经导管心脏修复系统1000应用于二尖瓣瓣环成形术中为例,说明本申请实施方式的经导管心脏修复系统1000的使用过程及工作原理:Please refer to FIG. 18 and FIG. 23 to FIG. 28 together. Taking the application of the transcatheter cardiac repair system 1000 in mitral valve annuloplasty as an example, the usage process and working principle:
S1、如图23所示,通过穿刺装置(图中未示)经股静脉(图中未示)穿刺,再通过导丝(图中未示)建立经股静脉-下腔静脉2-右心房3-房间隔4-左心房5-二尖瓣瓣环1的轨道;将导引鞘管500沿导丝导入,直至导引鞘管500的远端沿导丝输送至二尖瓣瓣环1附近后,撤出导丝。S1. As shown in Figure 23, puncture through the femoral vein (not shown) through a puncture device (not shown in the figure), and then establish a transfemoral vein-inferior vena cava 2-right atrium through a guide wire (not shown in the figure) 3-atrial septum 4-left atrium 5-the track of mitral valve annulus 1; introduce the guide sheath 500 along the guide wire until the distal end of the guide sheath 500 is delivered to the mitral valve annulus 1 along the guide wire Once in proximity, withdraw the guidewire.
S2、如图24和图25所示,进行与收紧线30的远端连接的第一个锚定组件10(如图28所示的锚定组件10a)的植入。具体地,首先,将锚定装置300穿装于输送鞘管201中并自输送鞘管201的远端穿出与第一个锚定组件10连接;然后,朝近端后撤锚定装置300,带动第一个锚定组件10进入输送鞘管201中,此时,第一个锚定组件10的穿线环121自通槽2012露于输送鞘管201的外部,与穿线环121连接的收紧线30及与收紧线30连接的输送线202位于输送鞘管201的外部;接着,将输送鞘管201推入导引鞘管500中并沿导引鞘管500输送,直至第一个锚定组件10输送至二尖瓣瓣环1附近并到达预定的治疗位点;最后,转动驱动管301,以将第一个锚定组件10锚入二尖瓣瓣环1。S2. As shown in FIGS. 24 and 25 , implant the first anchor component 10 connected to the distal end of the tightening wire 30 (the anchor component 10 a shown in FIG. 28 ). Specifically, firstly, the anchoring device 300 is worn in the delivery sheath 201 and passed out from the distal end of the delivery sheath 201 to connect with the first anchoring assembly 10; then, the anchoring device 300 is withdrawn toward the proximal end , driving the first anchoring assembly 10 into the delivery sheath 201, at this time, the threading ring 121 of the first anchoring assembly 10 is exposed to the outside of the delivery sheath 201 from the through groove 2012, and the threading ring 121 connected with The tightening line 30 and the delivery line 202 connected with the tightening line 30 are located outside the delivery sheath tube 201; then, the delivery sheath tube 201 is pushed into the guide sheath tube 500 and delivered along the guide sheath tube 500 until the first The anchoring assembly 10 is delivered to the vicinity of the mitral valve annulus 1 and reaches a predetermined treatment site; finally, the driving tube 301 is rotated to anchor the first anchoring assembly 10 into the mitral valve annulus 1 .
S3、如图26和图27所示,植入第一个锚定组件10后,后撤锚定装置300及输送鞘管201至体外并进行第一个间隔件20(如图28所示的间隔件20a)及第二个锚定组件10(如图28所示的锚定组件10b)的植入。首先,在输送线202的近端穿装第一个间隔件20,将输送线202的近端穿过推送杆600的导引孔601(如图26中所示的L1方向);然后,推送推送杆600直至将第一个间隔件20推送至导引鞘管500中(如图26中所示的L2方向),朝近端后撤推送杆600与输送线202分离;接着,将输送线202近端穿过第二个锚定组件10的穿线环121(第二个锚定组件10已经与锚定装置300远端连接并位于输送鞘管201中)并在导引鞘管500中朝远端推送输送鞘管201(如图27中所示的L3方向),通过输送鞘管201的推送将第一个间隔件20与第二个锚定组件10沿输送线202穿装于收紧线30上并输送至二尖瓣瓣环1(如图28所示)处;最后,将第二个锚定组件10锚入二尖瓣瓣环1。S3. As shown in FIGS. 26 and 27, after implanting the first anchoring assembly 10, withdraw the anchoring device 300 and the delivery sheath 201 to the outside of the body and carry out the first spacer 20 (as shown in FIG. 28 ). Implantation of the spacer 20a) and the second anchor component 10 (such as the anchor component 10b shown in FIG. 28). First, wear the first spacer 20 at the proximal end of the delivery line 202, pass the proximal end of the delivery line 202 through the guide hole 601 of the push rod 600 (direction L1 as shown in Figure 26); then, push Push the rod 600 until the first spacer 20 is pushed into the guide sheath 500 (L2 direction as shown in FIG. 26 ), withdraw the push rod 600 and separate the delivery wire 202 toward the proximal end; then, pull the delivery wire The proximal end of 202 passes through the threading loop 121 of the second anchor assembly 10 (the second anchor assembly 10 has been connected to the distal end of the anchoring device 300 and is located in the delivery sheath 201) and in the guide sheath 500 towards Push the delivery sheath 201 distally (L3 direction as shown in FIG. 27 ), and through the pushing of the delivery sheath 201, the first spacer 20 and the second anchor assembly 10 are worn along the delivery line 202 and tightened. Wire 30 and delivered to the mitral valve annulus 1 (as shown in FIG. 28 ); finally, the second anchor assembly 10 is anchored into the mitral valve annulus 1 .
S4、重复步骤S3,如图28所示,依次将其余的间隔件20和锚定组件10,从二尖瓣瓣环1的前三角区沿其后瓣环打入至后三角区(或者与其相反的方向),使得锚定组件10和间隔件20交替均匀分布于二尖瓣瓣环1上,其中,每个间隔件20位于每两个锚定组件10之间。S4. Repeat step S3. As shown in FIG. 28, the rest of the spacer 20 and the anchor assembly 10 are driven into the posterior triangle from the anterior triangle of the mitral annulus 1 along its posterior annulus (or with it) opposite direction), so that the anchoring assemblies 10 and the spacers 20 are alternately and evenly distributed on the mitral annulus 1, wherein each spacer 20 is located between every two anchoring assemblies 10.
S5、如图18和图28所示,在植入足够数量的锚定组件10和间隔件20后,朝近端撤出输送鞘管201及锚定装置300,利用收线器40进行卷绕并锁紧收紧线30以实现缩环。首先,将输送线202的近端穿过 与调节工具400的远端连接的收线器40;然后,在导引鞘管500中,沿输送线202将收线器40穿装于收紧线30上,并输送至收紧线30上的最后一个锚定组件10或者最后一个间隔件20附近;转动调节工具400的旋转管402以带动绕线轴42转动,使得收紧线30卷绕于绕线轴42上而收紧,直至二尖瓣反流减弱或者消失并停止转动旋转管402,此时,由于收线器40的止转轮45的止转作用,收紧线30锁紧于绕线轴42与壳体41之间的径向空间43内,收紧线30在二尖瓣瓣环1上保持一定的长度;最后,解除调节工具400与收线器40的连接及输送线202与收紧线30的连接,将调节工具400、输送线202及导引鞘管500自体内撤出,收线器40随收紧线30留存在二尖瓣瓣环1处,实现缩环以使二尖瓣反流减弱或者消失的治疗目标。S5. As shown in FIG. 18 and FIG. 28 , after implanting a sufficient number of anchor components 10 and spacers 20 , withdraw the delivery sheath 201 and the anchor device 300 toward the proximal end, and use the wire take-up device 40 for coiling And tighten the tightening line 30 to realize shrinkage. First, pass the proximal end of the delivery line 202 through the wire retractor 40 connected to the distal end of the adjustment tool 400; then, in the guiding sheath 500, thread the wire retractor 40 on the tightening wire along the delivery line 202 30, and delivered to the last anchor assembly 10 or the last spacer 20 on the tightening line 30; turn the rotating tube 402 of the adjustment tool 400 to drive the winding shaft 42 to rotate, so that the tightening line 30 is wound around the winding Tighten the spool 42 until the mitral valve regurgitation weakens or disappears and stops rotating the rotating tube 402. At this time, due to the anti-rotation effect of the anti-rotation wheel 45 of the take-up device 40, the tightening line 30 is locked on the spool 42 and the radial space 43 between the housing 41, the tightening wire 30 maintains a certain length on the mitral valve annulus 1; finally, the connection between the adjustment tool 400 and the wire retractor 40 and the connection between the delivery wire 202 and the retractor 40 are released. Tighten the connection of the wire 30, withdraw the adjustment tool 400, the delivery wire 202 and the guide sheath 500 from the body, and leave the wire take-up device 40 at the mitral annulus 1 along with the tightening wire 30, so as to shrink the ring so that the two The goal of treatment is the reduction or disappearance of cusp regurgitation.
应当理解,植入物100除了直接植入在心房侧的瓣环(二尖瓣瓣环1、三尖瓣瓣环)上,还可以植入在瓣环下,即植入物100还可以植入在二尖瓣瓣环下的左心室壁或三尖瓣瓣环下的右心室壁。其中,植入物100植入在左心室壁上尤其适用于治疗左心室功能异常导致的心脏衰竭以及功能性二尖瓣反流。导引鞘管500可以从股动脉穿刺,逆行通过主动脉瓣进入左心室,通过输送装置200及锚定装置300将植入物100植入在左心室壁上,收紧线30收紧后直接抑制左心室扩张而达到缩小二尖瓣瓣环的目的,这种环下成形可以保留二尖瓣的自然结构。也即是说,本申请的经导管心脏修复系统1000除了用于在瓣环成形术中收缩瓣环,还可用于在心室减容术中减小心室容积,其具体的使用过程与上述二尖瓣瓣环成形术的使用过程基本类似,在此不作赘述。It should be understood that, in addition to being directly implanted on the valve annulus (mitral valve annulus 1, tricuspid valve annulus) on the side of the atrium, the implant 100 can also be implanted under the valve annulus, that is, the implant 100 can also be implanted into the wall of the left ventricle below the mitral annulus or the wall of the right ventricle below the tricuspid annulus. Wherein, implanting the implant 100 on the wall of the left ventricle is especially suitable for treating heart failure and functional mitral regurgitation caused by abnormal function of the left ventricle. The guide sheath 500 can be punctured from the femoral artery, retrogradely enters the left ventricle through the aortic valve, and the implant 100 is implanted on the wall of the left ventricle through the delivery device 200 and the anchoring device 300, and the tightening wire 30 is tightened and directly The reduction of the mitral valve annulus is achieved by inhibiting the expansion of the left ventricle. This subannular annulus can preserve the natural structure of the mitral valve. That is to say, the transcatheter heart repair system 1000 of the present application is not only used for shrinking the valve ring during annuloplasty, but also can be used for reducing the volume of the ventricle during ventricular volume reduction. The use process of valve annuloplasty is basically similar and will not be repeated here.
在本说明书的描述中,参考术语“一些实施方式”、“示意性实施方式”、“示例”、“具体示例”、或“一些示例”等的描述意指结合该实施方式或示例描述的具体特征、结构、材料或者特点包含于本申请的至少一个实施方式或示例中。在本说明书中,对上述术语的示意性表述不一定指的是相同的实施方式或示例。而且,描述的具体特征、结构、材料或者特点可以在任何的一个或多个实施方式或示例中以合适的方式结合。In the description of this specification, descriptions with reference to the terms "some embodiments", "exemplary embodiments", "examples", "specific examples", or "some examples" mean that the specific embodiments described in conjunction with the embodiments or examples A feature, structure, material, or characteristic is included in at least one embodiment or example of the present application. In this specification, schematic representations of the above terms do not necessarily refer to the same embodiment or example. Furthermore, the described specific features, structures, materials or characteristics may be combined in any suitable manner in any one or more embodiments or examples.
尽管已经示出和描述了本申请的实施方式,本领域的普通技术人员可以理解:在不脱离本申请的原理和宗旨的情况下可以对这些实施方式进行多种变化、修改、替换和变型,本申请的范围由权利要求及其等同物限定。Although the embodiments of the present application have been shown and described, those skilled in the art can understand that various changes, modifications, substitutions and variations can be made to these embodiments without departing from the principle and spirit of the present application. The scope of the application is defined by the claims and their equivalents.

Claims (16)

  1. 一种可加速内皮化的植入物,其特征在于,包括:An implant capable of accelerating endothelialization, comprising:
    多个锚定组件,所述锚定组件用于锚入心脏组织;a plurality of anchor assemblies for anchoring into cardiac tissue;
    多个间隔件,所述间隔件在其轴向上具有弹性;以及a plurality of spacers having elasticity in their axial direction; and
    收紧线,所述多个锚定组件与所述多个间隔件交替穿装于所述收紧线上,所述收紧线的远端与用于锚入所述心脏组织的第一个所述锚定组件连接。Tightening wires, the plurality of anchoring components and the plurality of spacers are alternately worn on the tightening wires, the distal ends of the tightening wires are connected with the first one for anchoring into the heart tissue The anchor assembly is connected.
  2. 根据权利要求1所述的可加速内皮化的植入物,其特征在于,所述间隔件在其径向上还具有弹性,所述间隔件沿其轴向被压缩时,所述间隔件沿其径向扩张使所述间隔件的外周面与所述心脏组织贴合。The implant capable of accelerating endothelialization according to claim 1, wherein the spacer also has elasticity in its radial direction, and when the spacer is compressed along its axial direction, the spacer along its Radial expansion conforms the outer peripheral surface of the spacer to the cardiac tissue.
  3. 根据权利要求2所述的可加速内皮化的植入物,其特征在于,所述间隔件包括主体部,所述主体部具有轴向内腔,所述主体部采用形状记忆材料制成;The implant capable of accelerating endothelialization according to claim 2, wherein the spacer comprises a main body, the main body has an axial lumen, and the main body is made of a shape memory material;
    所述主体部沿其轴向被压缩使所述主体部沿其径向扩张。The body portion is compressed in its axial direction so that the body portion expands in its radial direction.
  4. 根据权利要求3所述的可加速内皮化的植入物,其特征在于,在自然状态下,所述主体部的径向尺寸沿其轴向由中部向两端逐渐减小。The implant capable of accelerating endothelialization according to claim 3, characterized in that, in a natural state, the radial dimension of the main body portion gradually decreases from the middle portion to both ends along its axial direction.
  5. 根据权利要求3所述的可加速内皮化的植入物,其特征在于,所述间隔件还包括两个固定件,所述固定件沿其轴向设有过线孔,两个所述固定件分别设于所述主体部的轴向两端,所述过线孔连通所述轴向内腔。The implant capable of accelerating endothelialization according to claim 3, wherein the spacer further comprises two fixing parts, and the fixing parts are provided with wire holes along the axial direction, and the two fixing parts The parts are respectively arranged at the two axial ends of the main body part, and the wire passing hole communicates with the axial inner cavity.
  6. 根据权利要求5所述的可加速内皮化的植入物,其特征在于,所述间隔件还包括刚性件,所述刚性件沿其轴向设有穿线孔,所述刚性件收容于所述轴向内腔中且位于所述两个固定件之间,所述穿线孔连通所述过线孔;The implant capable of accelerating endothelialization according to claim 5, wherein the spacer further comprises a rigid member, the rigid member is provided with a threading hole along its axial direction, and the rigid member is accommodated in the In the axial cavity and between the two fixing parts, the threading hole communicates with the threading hole;
    所述主体部处于自然状态时,所述刚性件至少与一所述固定件之间沿轴向存在间距。When the main body is in a natural state, there is an axial distance between the rigid member and at least one of the fixing members.
  7. 根据权利要求5所述的可加速内皮化的植入物,其特征在于,所述主体部为网状结构,所述固定件包括轴向套设的外套管及内套管,所述网状结构的自由端挤压收容于所述外套管和所述内套管之间。The implant capable of accelerating endothelialization according to claim 5, wherein the main body part is a mesh structure, the fixing member includes an outer sleeve and an inner sleeve axially sleeved, and the mesh The free end of the structure is squeezed and accommodated between the outer sleeve and the inner sleeve.
  8. 根据权利要求5所述的可加速内皮化的植入物,其特征在于,所述主体部包括多根间隔分布的支撑条,所述固定件为固定管,多根所述支撑条围绕所述固定管的周向布置。The implant capable of accelerating endothelialization according to claim 5, wherein the main body part includes a plurality of supporting bars distributed at intervals, the fixing member is a fixing tube, and a plurality of the supporting bars surround the Circumferential arrangement of fixed pipes.
  9. 根据权利要求3-8任一项所述的可加速内皮化的植入物,其特征在于,所述间隔件还包括覆膜,所述覆膜具有弹性,所述覆膜包覆于所述主体部的外部且与所述主体部固定连接。The implant capable of accelerating endothelialization according to any one of claims 3-8, characterized in that, the spacer further includes a covering film, the covering film is elastic, and the covering film covers the The outside of the main body is fixedly connected with the main body.
  10. 根据权利要求1所述的可加速内皮化的植入物,其特征在于,所述间隔件为压缩弹簧。The accelerated endothelialization implant according to claim 1, wherein the spacer is a compression spring.
  11. 根据权利要求1-8任一项所述的可加速内皮化的植入物,其特征在于,所述锚定组件包括锚钉及设于所述锚钉上的穿线结构,所述收紧线的远端与用于锚入所述心脏组织的第一个所述锚定组件的穿线结构连接,所述收紧线的其他部分滑动穿过用于锚入所述心脏组织的其他所述锚定组件的穿线结构。The implant capable of accelerating endothelialization according to any one of claims 1-8, wherein the anchor component comprises an anchor and a threading structure provided on the anchor, and the tightening thread The distal end of the tightening wire is connected to the threading structure of the first anchor assembly for anchoring into the heart tissue, and the other part of the tightening wire slides through the other anchors for anchoring into the heart tissue The threading structure of the given component.
  12. 根据权利要求1-8任一项所述的可加速内皮化的植入物,其特征在于,所述植入物还包括收线器,所述收线器包括壳体及可转动地设于所述壳体内的绕线轴,所述收紧线活动穿过所述壳体及所述绕线轴,所述绕线轴相对于所述壳体转动以卷绕所述收紧线,所述绕线轴停止转动时,所述收紧线被锁紧于所述绕线轴与所述壳体之间的径向空间内。The implant capable of accelerating endothelialization according to any one of claims 1-8, characterized in that, the implant further comprises a wire take-up, the wire take-up includes a housing and is rotatably arranged on The winding shaft in the housing, the tightening wire moves through the housing and the winding shaft, the winding shaft rotates relative to the housing to wind the tightening wire, the winding shaft When the rotation stops, the tightening wire is locked in the radial space between the winding shaft and the housing.
  13. 一种经导管心脏修复系统,其特征在于,所述经导管心脏修复系统包括输送装置、锚定装置及权利要求1-12任一项所述的可加速内皮化的植入物;A transcatheter heart repair system, characterized in that the transcatheter heart repair system comprises a delivery device, an anchoring device, and the implant capable of accelerating endothelialization according to any one of claims 1-12;
    所述输送装置包括输送鞘管,所述锚定装置活动穿装于所述输送鞘管的内腔中,所述锚定组件穿装于所述输送鞘管的远端内腔中,所述锚定组件与所述锚定装置的远端可拆卸连接,所述输送鞘管用于将所述锚定组件输送至所述心脏组织处,所述锚定装置用于驱动所述锚定组件锚入所述心脏组织。The delivery device includes a delivery sheath, the anchoring device is movably worn in the lumen of the delivery sheath, the anchor assembly is worn in the distal lumen of the delivery sheath, the An anchoring assembly is detachably connected to the distal end of the anchoring device, the delivery sheath is used to deliver the anchoring assembly to the heart tissue, and the anchoring device is used to drive the anchoring assembly to anchor into the cardiac tissue.
  14. 根据权利要求13所述的经导管心脏修复系统,其特征在于,所述锚定装置包括驱动管及穿装于所述驱动管中的连接杆,所述锚定组件的近端设有第一连接部,所述驱动管的远端设有与所述第一连接部可拆卸连接的第二连接部,所述连接杆沿所述驱动管的轴向穿设于配合连接的所述第一连接部及所述第二连接部中以保持所述驱动管与所述锚定组件之间的连接,所述驱动管用于驱动所述锚定组件锚入所述心脏组织。The transcatheter heart repair system according to claim 13, wherein the anchoring device comprises a driving tube and a connecting rod pierced in the driving tube, and the proximal end of the anchoring assembly is provided with a first A connecting part, the distal end of the driving tube is provided with a second connecting part that is detachably connected to the first connecting part, and the connecting rod passes through the first connecting part that is mated and connected along the axial direction of the driving tube. The connecting portion and the second connecting portion are used to maintain the connection between the driving tube and the anchoring assembly, and the driving tube is used to drive the anchoring assembly to anchor into the heart tissue.
  15. 根据权利要求13所述的经导管心脏修复系统,其特征在于,所述输送装置还包括输送线,所述输送线的远端与所述收紧线的近端连接。The transcatheter heart repair system according to claim 13, wherein the delivery device further comprises a delivery wire, the distal end of the delivery wire is connected to the proximal end of the tightening wire.
  16. 根据权利要求15所述的经导管心脏修复系统,其特征在于,所述经导管心脏修复系统还包括导引鞘管及推送杆,所述推送杆的远端设有导引孔,所述间隔件穿装于所述输送线上后,所述输送线活动穿过所述导引孔,所述推送杆沿所述输送线推送所述间隔件进入所述导引鞘管中,所述输送鞘管活动穿装于所述导引鞘管中以在所述导引鞘管中推送所述间隔件,以使所述间隔件沿所述输送线穿装于所述收紧线上。The transcatheter heart repair system according to claim 15, characterized in that, the transcatheter heart repair system further comprises a guide sheath and a push rod, the distal end of the push rod is provided with a guide hole, and the interval After a piece is worn on the delivery line, the delivery line moves through the guide hole, the push rod pushes the spacer along the delivery line into the guide sheath, and the delivery The sheath tube is movably threaded in the guiding sheath to push the spacer in the guiding sheath so that the spacer is threaded on the tightening line along the delivery line.
PCT/CN2022/130084 2021-12-31 2022-11-04 Implant capable of accelerating endothelialization and transcatheter cardiac repair system WO2023124540A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111671786.6 2021-12-31
CN202111671786.6A CN116407349A (en) 2021-12-31 2021-12-31 Implant capable of accelerating endothelialization and transcatheter heart repair system

Publications (1)

Publication Number Publication Date
WO2023124540A1 true WO2023124540A1 (en) 2023-07-06

Family

ID=86997563

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/130084 WO2023124540A1 (en) 2021-12-31 2022-11-04 Implant capable of accelerating endothelialization and transcatheter cardiac repair system

Country Status (2)

Country Link
CN (1) CN116407349A (en)
WO (1) WO2023124540A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049942A1 (en) * 2005-08-30 2007-03-01 Hindrichs Paul J Soft body tissue remodeling methods and apparatus
US20110166649A1 (en) * 2008-06-16 2011-07-07 Valtech Cardio Ltd. Annuloplasty devices and methods of deliver therefor
CN106821549A (en) * 2017-04-01 2017-06-13 上海纽脉医疗科技有限公司 Adjustable mitral valve forming ring
CN110381850A (en) * 2016-11-18 2019-10-25 复心公司 For promoting the myocardial implant load sharing device and method of LV function
CN110709029A (en) * 2017-03-28 2020-01-17 伊曼纽尔迪亚科尼有限公司 Minimally invasive implantable device and mitral valve implant system
US20210145584A1 (en) * 2019-10-29 2021-05-20 Valtech Cardio, Ltd. Annuloplasty and tissue anchor technologies
US20210401576A1 (en) * 2011-06-23 2021-12-30 Valtech Cardio Ltd. Annuloplasty implants

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049942A1 (en) * 2005-08-30 2007-03-01 Hindrichs Paul J Soft body tissue remodeling methods and apparatus
US20110166649A1 (en) * 2008-06-16 2011-07-07 Valtech Cardio Ltd. Annuloplasty devices and methods of deliver therefor
US20210401576A1 (en) * 2011-06-23 2021-12-30 Valtech Cardio Ltd. Annuloplasty implants
CN110381850A (en) * 2016-11-18 2019-10-25 复心公司 For promoting the myocardial implant load sharing device and method of LV function
CN110709029A (en) * 2017-03-28 2020-01-17 伊曼纽尔迪亚科尼有限公司 Minimally invasive implantable device and mitral valve implant system
CN106821549A (en) * 2017-04-01 2017-06-13 上海纽脉医疗科技有限公司 Adjustable mitral valve forming ring
US20210145584A1 (en) * 2019-10-29 2021-05-20 Valtech Cardio, Ltd. Annuloplasty and tissue anchor technologies

Also Published As

Publication number Publication date
CN116407349A (en) 2023-07-11

Similar Documents

Publication Publication Date Title
US8926696B2 (en) Adjustable annuloplasty devices and adjustment mechanisms therefor
US20230075875A1 (en) Method and transcatheter annuloplasty system for contracting heart tissue
US20200237516A1 (en) Myocardial implant load sharing device and methods to promote lv function
JP2007526011A (en) Tensioner and system for treating mitral regurgitation
CN106473791B (en) Left auricle plugging device with adjustable distance
WO2023029725A1 (en) Anti-tangling conveying device, and transcatheter annulus contraction system and application thereof
US20230024606A1 (en) Controllable guiding device for implantable apparatus
US20230277316A1 (en) Delivery system for aided replacement valve recapture and repositioning post-deployment
US20210068955A1 (en) Spring loaded self locking reversible anchor
WO2023124540A1 (en) Implant capable of accelerating endothelialization and transcatheter cardiac repair system
WO2023029726A1 (en) Anchor assembly having threading ring, implant, and transcatheter ring contraction system
CN115227308B (en) Lock and shear integrated device
CN114681165B (en) Locking structure and outer anchor for left ventricle volume-reducing device
WO2022241755A1 (en) Ring contraction apparatus for mitral valve annulus
US11844694B2 (en) Simplified coaxial shaft design delivery system and implant for mitral valve annulus reduction
CN114681145A (en) Implant and adjustable wire locking device
CN219166770U (en) Anti-winding conveying device and transcatheter heart repair system
CN215778922U (en) Implant and adjustable wire locking device
CN115429344B (en) Internal anchoring device, ventricular volume reduction system and method for regulating and releasing internal anchoring device
CN211934165U (en) Valve suture instrument
WO2021135450A1 (en) Chordae tendineae regulation implant, chordae tendineae regulation device, and chordae tendineae regulation system
US11678987B2 (en) Coil and barb anchors for heart valve repair devices
CN116407357A (en) Anchor implantation device and transcatheter repair system
WO2023124187A1 (en) Anti-slip artificial chordae tendineae implantation device and system
CN117731451A (en) Valve leaflet capturing device, system and artificial heart valve system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22913803

Country of ref document: EP

Kind code of ref document: A1